TW200832019A - Liguid crystal alignment agent and liquid crystal display element - Google Patents

Liguid crystal alignment agent and liquid crystal display element Download PDF

Info

Publication number
TW200832019A
TW200832019A TW096141960A TW96141960A TW200832019A TW 200832019 A TW200832019 A TW 200832019A TW 096141960 A TW096141960 A TW 096141960A TW 96141960 A TW96141960 A TW 96141960A TW 200832019 A TW200832019 A TW 200832019A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
group
crystal alignment
alignment agent
above formula
Prior art date
Application number
TW096141960A
Other languages
Chinese (zh)
Inventor
Hiroyuki Yasuda
Eiji Hayashi
Original Assignee
Jsr Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jsr Corp filed Critical Jsr Corp
Publication of TW200832019A publication Critical patent/TW200832019A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/20Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the epoxy compounds used
    • C08G59/32Epoxy compounds containing three or more epoxy groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nonlinear Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Epoxy Resins (AREA)

Abstract

The present invention provides a liquid crystal alignment agent, which maintains the voltage holding ratio while reducing accumulated charges and further has outstanding printability. The liquid crystal alignment agent comprises a compound as shown in following general formula (1). (Wherein, A and B are individually hydrogen atom or glycidyl group, R1-R4 are individually hydrogen atom or glycidyl group, X is a group having two valence bonds as shown in following formula (X1) or (X2), Y is a group having two valence bonds as shown in following formula (Y1), (Y2) or (Y3). (Wherein, R5-R14 are individually hydrogen atom, alkyl group, alkoxyl group or alkyl group comprising fluorine, Z is a group having two valence bonds expressed by -O-, -NH-, -CH2-, -SO2-, -C(CH3)2- or -C(CF3)2-.))

Description

200832019 九、發明說明: 【發明所屬之技術領域】 本發明涉及用於形成液晶顯示兀件的液晶配向膜的液 晶配向劑以及液晶顯示元件。更詳細地說,涉及能夠形成 電性能良好且印刷性良好的液晶配向膜的液晶配向劑以及 使用它的液晶顯示元件。 【先前技術】 目前,作爲液晶顯示元件,已知具有所謂T N (T w i s t e d r、 k Nematic)型液晶胞的TN型液晶顯示元件,其在設置了透明 導電膜的基板表面上形成由聚醯胺酸、聚醯亞胺等所構成 的液晶配向膜,作爲液晶顯示元件用的基板,將2片該基 板相對設置,在其間隙內形成具有正介電各向異性的向列 型液晶層,構成夾層結構的晶胞,液晶分子的長軸從一片 基板向另一片基板連續地扭轉90度。並且,還開發了與 TN型液晶顯示元件相比對比度更高、其視角依賴性更小的 STN(Super Twisted Nematic)型液晶顯示元件和垂直配向型 液晶顯示元件。STN型液晶顯示元件將在向列型液晶中摻 合了作爲光學活性物質的手性劑的液晶作爲液晶使用,其 利用通過使液晶分子的長軸在基板間處於連續扭轉1 80度 以上幅度的狀態而產生的雙折射效果。 相比之下,如非專利文獻1和專利文獻1所揭示,提 出了在透明導電膜上形成突起來控制液晶配向方向之被稱 作爲 MVA(Multi Domain Vertical Alignment)型的垂直配向 型液晶顯示元件。MVA方式的液晶顯示元件不僅視角、對 200832019 比度等優良,而且在形成液晶配向膜的過程中還可以不進 行打磨(rubbing)處理等,在製程方面也是優良的。作爲適 用於TN、STN、MVA方式的液晶配向膜,要求有液晶顯示 元件的殘像消除時間短等性能。另外,作爲形成這些液晶配 向膜所用的配向劑,要求在平版印刷中具有優良的印刷性。 【非專利文獻1】“液晶” Vol. 3 No. 2 1 1 7( 1 999年) 【專利文獻1】日本特開平1 1 一 25 8 605號公報 【專利文獻2】日本特開平6 — 2223 66號公報 【專利文獻3】日本特開平6 - 2 8 1 9 3 7號公報 【專利文獻4】日本特開平5 — 1 07 5 44號公報 【非專利文獻 2】K. Hasegawa, Polymer Journal. Vol. 31, No. 2,206 ( 1 9 99) 【專利文獻5】日本特開2000 — 4468 3號公報 【專利文獻6】國際公開第2002/ 1 00949號手冊 【發明內.容】 本發明是鑒於上述問題而作出的,其目的是提供在維 持電壓保持率的同時又使蓄積電荷減少、並且具有優良的 印刷性的液晶配向劑,以及使用它的液晶顯示元件。 本發明的其他目的和優點可以由以下的說明看出。 本發明的上述目的,第一,由一種液晶配向劑(以下稱 爲“第一液晶配向劑”)達成,其含有下述通式(1)表示的化 合物, 200832019 R1 \ N—Y—N R2 i X-200832019 IX. Description of the Invention: TECHNICAL FIELD The present invention relates to a liquid crystal alignment agent and a liquid crystal display element for forming a liquid crystal alignment film of a liquid crystal display element. More specifically, the present invention relates to a liquid crystal alignment agent capable of forming a liquid crystal alignment film having good electrical properties and excellent printability, and a liquid crystal display element using the same. [Prior Art] At present, as a liquid crystal display element, a TN type liquid crystal display element having a so-called TN (T wistedr, k Nematic) type liquid crystal cell is known, which is formed of polylysine on the surface of a substrate provided with a transparent conductive film. A liquid crystal alignment film made of a polyimine or the like is used as a substrate for a liquid crystal display element, and two substrates are opposed to each other, and a nematic liquid crystal layer having positive dielectric anisotropy is formed in the gap to form an interlayer. The unit cell of the structure, the long axis of the liquid crystal molecules is continuously twisted by 90 degrees from one substrate to the other substrate. Further, STN (Super Twisted Nematic) type liquid crystal display elements and vertical alignment type liquid crystal display elements having higher contrast and smaller viewing angle dependence than TN type liquid crystal display elements have been developed. The STN type liquid crystal display element uses a liquid crystal in which a chiral agent as an optically active substance is blended in a nematic liquid crystal as a liquid crystal by using a long axis of liquid crystal molecules to be continuously twisted by more than 180 degrees between substrates. The birefringence effect produced by the state. In contrast, as disclosed in Non-Patent Document 1 and Patent Document 1, a vertical alignment type liquid crystal display element called MVA (Multi Domain Vertical Alignment) type in which protrusions are formed on a transparent conductive film to control a liquid crystal alignment direction is proposed. . The liquid crystal display element of the MVA type is excellent not only in the viewing angle but also in the ratio of 200832019, and also in the process of forming the liquid crystal alignment film, which is not required to be rubbed, and is excellent in the process. As a liquid crystal alignment film suitable for the TN, STN, and MVA systems, it is required that the residual image erasing time of the liquid crystal display element is short. Further, as an alignment agent for forming these liquid crystal alignment films, it is required to have excellent printability in lithography. [Non-Patent Document 1] "Liquid Crystal" Vol. 3 No. 2 1 1 7 (1 999) [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei No. Hei. [Patent Document 3] Japanese Patent Laid-Open Publication No. Hei. No. Hei. No. Hei. No. Hei No. 5 - 1 07 5 No. 4 [Patent Document 4] Japanese Patent Laid-Open Publication No. Hei 5 No. 1 07 5 44 [Non-Patent Document 2] K. Hasegawa, Polymer Journal. Vol. 31, No. 2,206 (1 9 99) [Patent Document 5] Japanese Laid-Open Patent Publication No. 2000-4468-3 [Patent Document 6] International Publication No. 2002/00 00949 [Invention] The present invention In view of the above problems, it is an object of the invention to provide a liquid crystal alignment agent which has a reduced charge charge while maintaining a voltage holding ratio and which has excellent printability, and a liquid crystal display element using the same. Other objects and advantages of the invention will be apparent from the description which follows. The above object of the present invention, first, is achieved by a liquid crystal alignment agent (hereinafter referred to as "first liquid crystal alignment agent") containing a compound represented by the following formula (1), 200832019 R1 \ N-Y-N R2 i X-

R3R3

N—Y~Ni 、 BN—Y~Ni, B

(式中,A和B各自獨立地爲氫原子或者縮水甘油基, R1〜R4各自獨立地爲氫原子或者縮水甘油基,X爲下述式 (XI)或(X2)表示的2價基團,(wherein, A and B are each independently a hydrogen atom or a glycidyl group, and R1 to R4 are each independently a hydrogen atom or a glycidyl group, and X is a divalent group represented by the following formula (XI) or (X2); ,

(X1)(X1)

(X2) Y爲下述式(Yl)、(Y2)或(Y3)表示的2價基團, 200832019(X2) Y is a divalent group represented by the following formula (Yl), (Y2) or (Y3), 200832019

(式中,R5〜R14各自獨立地爲氫原子、烷基、烷氧基或 含氟烷基,Z 爲一〇一、一NH—、一 CH2—、一 S〇2-、一 C(CH3)2—或者一C(CF3)2—表示的2價基團)。 本發明的上述目的,第二,由一種液晶配向劑(以下稱 爲“第二液晶配向劑”)達成,其含有由下述通式(1 ’ )表示 的化合物與四羧酸二酐反應所得的聚醯胺酸,(wherein R5 to R14 are each independently a hydrogen atom, an alkyl group, an alkoxy group or a fluorine-containing alkyl group, and Z is a mono-, a-NH-, a CH2-, a S-2-, a C-CH3 2—or a divalent group represented by C(CF3)2—). The above object of the present invention, and secondly, is achieved by a liquid crystal alignment agent (hereinafter referred to as "second liquid crystal alignment agent") which contains a compound represented by the following general formula (1 ') and a tetracarboxylic dianhydride. Polylysine,

200832019 (式中,A、B、X和γ與上述通式(1)相同,R1〜R4 爲氫原子)。 本發明的上述課題,第三,由一種液晶顯示元件達成, 其具有由上述任一種液晶配向劑形成的液晶配向膜。 【實施方式】 本發明的第一液晶配向劑含有上述式(1)表示的化合 物。 ^ 在上述式(Y1)〜(Y3)中,R5〜R14各自獨立地爲氫原 f \ 子、烷基、烷氧基或者含氟烷基。 作爲上述院基,較佳爲碳數爲1〜6的院基,作爲其具 體的例子,可以舉出甲基、乙基、正丙基、異丙基、正丁 基、2-甲基-丙基、3-甲基-丙基、正戊基、正己基等。 作爲上述烷氧基,較佳爲碳數爲1〜6的烷氧基,作爲 其具體的例子,可以舉出甲氧基、乙氧基、正丙氧基、異 丙氧基、正丁氧基、2-甲基-丙氧基、3-甲基-丙氧基、正戊 氧基、正己氧基等。 作爲上述含氟烷基,可以舉出—CF3基、一 CH2CF3基、 〜CF2CF3基等。 作爲上述式中的R5〜R14,較佳爲氫原子、甲基、乙基 或者一 CF3基。 另外,上述式(Y2)中的Z爲一〇一、一NH—、一 CH2—、 〜S〇2—、一 C(CH3)2—或者—C(CF3)2—表示的 2價基團, 其中較佳爲一◦一、一 NH—、一 CH2—、一 C(CH3)2—或者一 C ( C F 3 ) 2 —。 -10- 200832019 上述式(1)中,A、B、X、Y和R1〜R4可以使各自較佳 的基團進行任意的組合。 上述式(1)表示的化合物中,作爲特佳的,可以舉出下 述(A)或(B)之化合物。 (A) 上述式(1)中,Y爲上述式(Y1)或(Y2)表示的2價基 團的化合物。 (B) 上述式(1)中,A和B爲氫原子,R1〜R4各自獨立地 爲氫原子或縮水甘油基,但R 1〜R4中至少一個爲縮水甘油 f ; 基的化合物。 作爲上述式(1)表示的較佳的具體化合物,可以舉出以 下的化合物。 -11- 200832019200832019 (wherein A, B, X and γ are the same as the above formula (1), and R1 to R4 are a hydrogen atom). The above object of the present invention is, in a third aspect, achieved by a liquid crystal display device comprising a liquid crystal alignment film formed of any one of the above liquid crystal alignment agents. [Embodiment] The first liquid crystal alignment agent of the present invention contains the compound represented by the above formula (1). ^ In the above formulae (Y1) to (Y3), R5 to R14 are each independently a hydrogen atom f \ , an alkyl group, an alkoxy group or a fluorine-containing alkyl group. As the above-mentioned base, a hospital base having a carbon number of 1 to 6 is preferable, and specific examples thereof include a methyl group, an ethyl group, a n-propyl group, an isopropyl group, an n-butyl group, and a 2-methyl group. Propyl, 3-methyl-propyl, n-pentyl, n-hexyl and the like. The alkoxy group is preferably an alkoxy group having 1 to 6 carbon atoms, and specific examples thereof include a methoxy group, an ethoxy group, a n-propoxy group, an isopropoxy group, and a n-butoxy group. Base, 2-methyl-propoxy, 3-methyl-propoxy, n-pentyloxy, n-hexyloxy and the like. Examples of the fluorine-containing alkyl group include a -CF3 group, a CH2CF3 group, and a CF2CF3 group. R5 to R14 in the above formula are preferably a hydrogen atom, a methyl group, an ethyl group or a CF3 group. Further, Z in the above formula (Y2) is a divalent group represented by mono-, one-NH-, one-CH2-, ~S〇2-, one C(CH3)2- or -C(CF3)2-. Preferably, it is mono-, one-NH-, one-CH2-, one C(CH3)2- or one C(CF3)2-. -10- 200832019 In the above formula (1), A, B, X, Y and R1 to R4 may be used in any combination of preferred groups. Among the compounds represented by the above formula (1), particularly preferred are the compounds of the following (A) or (B). (A) In the above formula (1), Y is a compound of a divalent group represented by the above formula (Y1) or (Y2). (B) In the above formula (1), A and B are each a hydrogen atom, and R1 to R4 are each independently a hydrogen atom or a glycidyl group, but at least one of R 1 to R 4 is a glycidyl group. Preferred specific compounds represented by the above formula (1) include the following compounds. -11- 200832019

-12- 200832019-12- 200832019

-13- 200832019-13- 200832019

OMSMOOMSMO

OMSnoOMSno

3 Y 3 Η - Η clcic3 Y 3 Η - Η clcic

/\/\

££

CO ϊ 3 FI F CIC1CCO ϊ 3 FI F CIC1C

晶 液酐 二二 第酸 的羧 明四 發與 本物 合 化 反 的表 \i/ 示’ 表(1 丨式 (1述 式上 述 上 由 有 含 劑 向 配 酸 胺 醯 聚 的 得 所 應 B /X 或 X)/ A Γ\ 述 下 出 舉 以 可 的 佳 特 爲 作 中 物 合 。 化物 的合 示化 -14- 200832019 (A’ )上述式(1’ )中,Y爲上述式(Y1)或(Y2)表示的2 價基團的化合物。 (Β’ )上述式(1’ )中,Α和Β爲氫原子的化合物。 作爲上述式(1 ’)表示的較佳的具體化合物,可以舉出 以下的化合物。The table of the carboxylic acid dicarboxylic acid of the dianhydride dicarboxylic acid is the same as the table of the chemical composition of the compound \i/ shown in the table (1 丨 (the above formula is obtained from the inclusion of the agent to the acid amine) /X or X)/ A Γ\ The following is a combination of the possible properties of the product. The compounding of the compound-14- 200832019 (A' ) In the above formula (1'), Y is the above formula ( a compound of a divalent group represented by Y1) or (Y2). (Β') A compound of the above formula (1') wherein hydrazine and hydrazine are hydrogen atoms. Preferred specific compound represented by the above formula (1 ') The following compounds can be mentioned.

-NH 2 h2n-〇-nh"〇~〇-nhhQ^-NH 2 h2n-〇-nh"〇~〇-nhhQ^

OM^WUO clolcOM^WUO clolc

CF3丨 i 丨CFCF3丨 i 丨CF

OMSnoOMSno

3 1 3 F I F ??c3 1 3 F I F ??c

-15- 200832019-15- 200832019

ΟΠ&ΜΟΟΠ&ΜΟ

onsnoOnsno

3 T 3 F - F clcic3 T 3 F - F clcic

3 1 3 F 1 F C—C—C3 1 3 F 1 F C—C—C

作爲通過上述式(1 ’ )表示的化合物與四羧酸二酐反 應合成聚醯胺酸時可以使用的四羧酸二酐,可以舉出 1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧 酸二酐、2,3,5-三羧基環戊基醋酸二酐、l,3,3a,4,5,9b-六氧 -5-(四氫- 2,5-二氧代-3-呋喃基)-萘[l,2-c]呋喃-1,3-二酮、順 -16 - 200832019 式-3,7-二丁基環辛-1,5-二烯-1,2,5,6-四狻酸二酐、3,5,6-三 羰基-2-羧基降冰片烷- 2:3,5:6-二酐、l,3,3a,4,5,9b -六氫- 8-甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[1,2-〇:]呋喃-1,3-二 酮、3-氧雜雙環[3.2.1]辛烷_2,4·二酮-6-螺-3’ -(四氫呋喃 -2’ ,5’ -二酮)、5-(2,5 -二氧代四氫-3-呋喃基)-3 -甲基-3-環 己烯-1,2-二羧酸酐、3,5,6-三羧基-2-羧基降冰片烷- 2:3,5:6-二酐、4,9-二氧雜三環[5.3.1.02’6]十一烷。^”,…-四酮〜均 苯四酸二酐等。這些酸酐可以僅使用1種,也可以將2種 r、\ 以上組合使用。 在通過上述式(1 ’)表示的化合物與四羧酸二酐反應 合成聚醯胺酸時,還可以與上述式(1 ’ )表示的化合物同時 倂用其他的二胺。作爲此處可以使用的較佳的其他二胺, 可以舉出例如對-苯二胺、4,4’ -二胺基二苯基甲烷、4,4’ - 二胺基二苯基硫醚、2,2’ -二甲基-4,4’ -二胺基聯苯、1,5- 二胺基萘、2,7-二胺基芴、9,9-二甲基-2,7-二胺基芴、4,4’-二胺基二苯基醚、2,2-二[4-(4-胺基苯氧基)苯基]丙烷、9,9· ‘二(4-胺基苯基)芴、2,2-二[4-(4-胺基苯氧基)苯基]六氟丙 烷、2,2-二(4-胺基苯基)六氟丙烷、4,4’ -(對-伸苯基二異亞 丙基)二苯胺、4,4’ -(間-伸苯基二異亞丙基)二苯胺、1,4- 環己烷二胺、4,4’ -伸甲基二(環己胺)、1,4-二(4-胺基苯氧 基)苯、4,4’ -二(4-胺基苯氧基)聯苯、2,6-二胺基吡啶、3,4- 二胺基吡啶、2,4 -二胺基嘧啶、3,6 -二胺基吖啶、3,6 -二胺 基咔唑、N-甲基-3,6-二胺基咔唑、N-乙基-3,6-二胺基咔唑、 N-苯基-3,6-二胺基咔唑、N,N,-二(4-胺基苯基)-聯苯胺、 -17· 200832019 N,N’ -二(4-胺基苯基)-N,N’ -二甲基-聯苯胺等。這些其他 二胺可以僅使用1種,或者將2種以上組合使用。 當將其他二胺與上述式(1 ’)表示的化合物同時倂用 時,作爲其他二胺的用量,相對於上述式(1,)表示的化合 物與其他二胺的合計量,較佳爲5 0重量%以下。 由上述式(1 ’ )表示的化合物與四羧酸二酐的聚醯胺 酸的合成,作爲本發明液晶配向劑之任意添加成分之一的 聚醯胺酸的合成方法,可以與後述方法同樣地進行。 本發明液晶配向劑含有藉由上述式(1)表示的化合物 或者上述式(1 ’ )表示的化合物與四羧酸二酐反應所得的 聚醯胺酸作爲必需成分,但除此之外,還可以含有選自由 具有下述式(I 一 1)表示的重複單元的聚醯胺酸和具有下述 式(I - 2)表示的重複單元的聚齒亞胺所組成群組中的至少 一種、接著性提升劑等, / HO〇a .COOH \ (J (1-1 ) —V-HNOC CONH—Q14-The tetracarboxylic dianhydride which can be used when the compound represented by the above formula (1 ') is reacted with a tetracarboxylic dianhydride to synthesize polyamic acid, and 1,2,3,4-cyclobutane tetracarboxylic acid is mentioned. Dihydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 1,3,3a,4 ,5,9b-hexaoxy-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]furan-1,3-dione, cis-16 - 200832019 Formula 3,7-dibutylcyclooctane-1,5-diene-1,2,5,6-tetradecanoic acid dianhydride, 3,5,6-tricarbonyl-2-carboxynorbornane-2 :3,5:6-dianhydride, l,3,3a,4,5,9b-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)- Naphthalene [1,2-〇:]furan-1,3-dione, 3-oxabicyclo[3.2.1]octane-2,4·dione-6-spiro-3'-(tetrahydrofuran-2' , 5'-dione), 5-(2,5-dioxotetrahydro-3-furanyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 3,5, 6-Tricarboxy-2-carboxynorbornane-2:3,5:6-dianhydride, 4,9-dioxatricyclo[5.3.1.0'6]undecane. ^", ... - tetraketone to pyromellitic dianhydride, etc. These acid anhydrides may be used alone or in combination of two kinds of r and \. The compound represented by the above formula (1 ') and tetracarboxylic acid. When the acid dianhydride is reacted to synthesize polyglycine, another diamine may be used together with the compound represented by the above formula (1 '). Preferred other diamines which can be used herein may, for example, be - Phenylenediamine, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfide, 2,2'-dimethyl-4,4'-diaminobiphenyl 1,5-Diaminonaphthalene, 2,7-diaminoguanidine, 9,9-dimethyl-2,7-diaminoguanidine, 4,4'-diaminodiphenyl ether, 2 ,2-bis[4-(4-aminophenoxy)phenyl]propane, 9,9·'bis(4-aminophenyl)anthracene, 2,2-di[4-(4-amino) Phenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4'-(p-phenylphenyldiisopropylidene)diphenylamine, 4, 4'-(m-phenylphenyldiisopropylidene)diphenylamine, 1,4-cyclohexanediamine, 4,4'-methylbis(cyclohexylamine), 1,4-bis(4) -aminophenoxy)benzene, 4,4 - bis(4-aminophenoxy)biphenyl, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminoacridine , 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6- Diaminocarbazole, N,N,-bis(4-aminophenyl)-benzidine, -17· 200832019 N,N'-bis(4-aminophenyl)-N,N'-dimethyl Further, these other diamines may be used alone or in combination of two or more. When other diamines are used together with the compound represented by the above formula (1 '), the amount of other diamines is used. The total amount of the compound represented by the above formula (1) and the other diamine is preferably 50% by weight or less. The polyamine derivative of the compound represented by the above formula (1 ') and the tetracarboxylic dianhydride The method for synthesizing polylysine which is one of the optional components of the liquid crystal alignment agent of the present invention can be carried out in the same manner as the method described below. The liquid crystal alignment agent of the present invention contains the compound represented by the above formula (1) or the above. Formula (1 ') means The polyamic acid obtained by reacting a compound with a tetracarboxylic dianhydride is an essential component, but may further contain a polyamic acid selected from the group consisting of a repeating unit represented by the following formula (I-1) and having a lower At least one of the group consisting of polydentimine of the repeating unit represented by the formula (I-2), an adhesion promoter, etc., /HO〇a.COOH \ (J (1-1) - V-HNOC CONH —Q14-

200832019 (式中,P2爲4價的有機基團,且Q2爲2價的有機基 團)。 具有上述式(I - 1)表示的重複單元的聚醯胺酸可以通 過四羧酸二酐與二胺的反應合成,具有上述式(1一 2)表示的 重複單元的聚醯亞胺可以通過使具有上述式(I 一丨)中pi爲 P2、Q1爲Q2的重複單元的聚醯胺酸脫水閉環而製得。 作爲具有上述式(I 一 1)表示的重複單元的聚醯胺酸的 合成中所用的四羧酸二酐,可以舉出例如脂環式四羧酸二 ^ \ 酐、脂肪族四羧酸二酐、芳香族四羧酸二酐等。 作爲上述脂環式四羧酸二酐,例如,可以舉出1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二 酐、1,3 -二甲基-1,2,3,4 -環丁烷四羧酸二酐、1,3 -二氯 -1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷 四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、ι,2,4,5-環己烷四 羧酸二酐、3,3’ ,4,4’ -二環己基四羧酸二酐、順式-3,7-二 丁基環辛-1,5-二烯-1,2,5,6-四羧酸二酐、2,3,5-三羧基環戊 基醋酸二酐、3,5,6-三羰基-2-羧基降冰片烷-2:3,5:6-二酐、 2,3,4,5-四氫呋喃四羧酸二酐、1,3,3&,4,5,91)-六氫-5-(四氫 -2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、 1,3,3&,4,5,91)-六氫-5-甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,913-六氫-5-乙基-5-(四 氫-2,5-二氧代-3-呋喃基)-萘[1,2-(:]-呋喃-1,3-二酮、 1,3,3&,4,5,91)-六氫-7-甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,913-六氫-7-乙基-5-(四 -19 - 200832019 氫-2,5 -二氧代-3 -呋喃基)-萘[1,2 · c ]-呋喃-1,3 -二酮、 1,3,33,4,5,91六氫-8-甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-8-乙基-5-(四 氫-2,5-二氧代-3-呋喃基)-萘[1,2-(:]-呋喃-1,3-二酮、 l,3,3a,4,5,9b-六氫-5,8-二甲基- 5-(四氫- 2,5-二氧代-3-呋喃 基)-萘[l,2-c]-呋喃-1,3-二酮、5-(2,5-二氧代四氫呋喃亞甲 基)-3-甲基-3-環己烯-1,2-二羧酸二酐、雙環[2.2.2]-辛-7-烯 -2,3,5,6-四羧酸二酐、3-氧雜雙環[3.2.1]辛烷-2,4-二酮-6-螺-3’ -(四氫呋喃-2’ ,5’ -二酮)、5-(2,5-二氧代四氫-3-呋 喃基)-3-甲基-3-環己烯-1,2-二羧酸酐、3,5,6-三羧基-2-羧基 降冰片烷胃2:3,5:6-二酐、4,9-二氧雜三環[5.3.1.02’6]十一烷 -3,5,8,10-四酮、下述式(I)和(II)表示的化合物等,200832019 (wherein P2 is a tetravalent organic group and Q2 is a divalent organic group). The polyamic acid having the repeating unit represented by the above formula (I-1) can be synthesized by a reaction of a tetracarboxylic dianhydride and a diamine, and the polyimine having the repeating unit represented by the above formula (1 to 2) can be passed. A polyglycine having a repeating unit of pi of P2 and Q1 of Q2 in the above formula (I) is dehydrated and closed. The tetracarboxylic dianhydride used in the synthesis of the polyamic acid having the repeating unit represented by the above formula (I-1) may, for example, be an alicyclic tetracarboxylic acid anhydride or an aliphatic tetracarboxylic acid. Anhydride, aromatic tetracarboxylic dianhydride, and the like. Examples of the alicyclic tetracarboxylic dianhydride include 1,2,3,4-cyclobutanetetracarboxylic dianhydride and 1,2-dimethyl-1,2,3,4-ring. Butane tetracarboxylic dianhydride, 1,3 -dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3 -dichloro-1,2,3,4-cyclobutane Alkanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic acid Dianhydride, iota, 2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride, cis-3,7-dibutyl ring Oct-1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 3,5,6-tricarbonyl-2-carboxyl Norbornane-2:3,5:6-dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1,3,3&,4,5,91)-hexahydro-5-( Tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&,4,5,91)-six Hydrogen-5-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&amp ;,4,5,913-hexahydro-5-ethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1,2-(:]-furan-1,3- Diketone, 1,3,3&,4,5,91)- Hexahydro-7-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3, 3&,4,5,913-hexahydro-7-ethyl-5-(tetra-19-200832019 hydrogen-2,5-dioxo-3-furanyl)-naphthalene[1,2 · c]-furan- 1,3 -dione, 1,3,33,4,5,91 hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l, 2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-ethyl-5-(tetrahydro-2,5-dioxo-3- Furyl)-naphthalene [1,2-(:]-furan-1,3-dione, l,3,3a,4,5,9b-hexahydro-5,8-dimethyl-5-(four Hydrogen-2,5-dioxo-3-furanyl)-naphthalene[l,2-c]-furan-1,3-dione, 5-(2,5-dioxotetrahydrofuranmethylene)- 3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride, bicyclo[2.2.2]-oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3- Oxabicyclo[3.2.1]octane-2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5'-dione), 5-(2,5-dioxotetrahydro) -3-furanyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 3,5,6-tricarboxy-2-carboxynorbornane stomach 2:3,5:6- Dihydride, 4,9-dioxatricyclo[5.3.1.0''6]undecane-3,5,8,10-tetraketone, the following formula I) and compound (II), or the like,

(式中,R15和R17表示具有芳香環的2價有機基團,R1 和R18表示氫原子或者烷基,複數個存在的R16和R18各自 可以相同,也可以不同)。 -20- 200832019 作爲上述脂肪族四羧酸二酐,可以舉出例如丁烷四羧 酸二酐等。 作爲上述芳香族四羧酸二酐,可以舉出例如均苯四酸 二酐、3,3’ ,4,4’ -二苯酮四羧酸二酐、3,3’ ,4,4’ -聯苯基 颯四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二 酐、3,3’ ,4,4’ -聯苯基醚四羧酸二酐、3,3’ ,4,4’ -二甲基 二苯基矽烷四羧酸二酐、3,3’ ,4,4’ -四苯基矽烷四羧酸二 酐、1,2,3,4-呋喃四羧酸二酐、4,4’ -二(3,4-二羧基苯氧基) r 、 二苯基硫醚二酐、4,4’ -二(3,4-二羧基苯氧基)二苯基颯二 酐、4,4’ -二(3,4-二羧基苯氧基)二苯基丙烷二酐、 3,3’ ,4,4’ -全氟異亞丙基二苯二甲酸二酐、3,3’ ,4,4’ - 聯苯四羧酸二酐、2,2’ ,3,3’ -聯苯四羧酸二酐、二(苯二甲 酸)苯膦氧化物二酐、對-伸苯基-二(三苯基苯二甲酸)二 酐、間-伸苯基-二(三苯基苯二甲酸)二酐、二(三苯基苯二 甲酸)-4,4’ -二苯醚二酐、二(三苯基苯二甲酸)-4,4’ -二苯 基甲烷二酐、乙二醇-二(脫水偏苯三酸酯)、丙二醇-二(脫 ‘ 水偏苯三酸酯)、1,4-丁二醇-二(脫水偏苯三酸酯)、1,6-己 二醇-二(脫水偏苯三酸酯)、1,8-辛二醇-二(脫水偏苯三酸 酯)、2,2-二(4-羥苯基)丙烷-二(脫水偏苯三酸酯)、下述式(2) 〜(5 )表示的化合物等。 -21 - 200832019(wherein R15 and R17 represent a divalent organic group having an aromatic ring, R1 and R18 represent a hydrogen atom or an alkyl group, and a plurality of R16 and R18 which are present may be the same or different). -20-200832019 The above-mentioned aliphatic tetracarboxylic dianhydride may, for example, be butane tetracarboxylic acid dianhydride. Examples of the aromatic tetracarboxylic dianhydride include pyromellitic dianhydride, 3,3', 4,4'-benzophenonetetracarboxylic dianhydride, and 3,3',4,4'- Biphenyl sulfonium tetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3',4,4' - Biphenyl ether tetracarboxylic dianhydride, 3,3',4,4'-dimethyldiphenylnonane tetracarboxylic dianhydride, 3,3',4,4'-tetraphenylnonane tetracarboxylic acid Dihydride, 1,2,3,4-furantetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)r, diphenyl sulfide dianhydride, 4,4' - Bis(3,4-dicarboxyphenoxy)diphenylphosphonium dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride, 3,3', 4, 4'-Perfluoroisopropylidenedicarboxylic dianhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride, 2,2',3,3'-biphenyltetracarboxylic acid Anhydride, di(phthalic acid) phenylphosphine oxide dianhydride, p-phenylene-bis(triphenylphthalic acid) dianhydride, m-phenylene-bis(triphenylphthalic acid) dianhydride , bis(triphenylphthalic acid)-4,4'-diphenyl ether dianhydride, bis(triphenylbenzene) Formic acid)-4,4'-diphenylmethane dianhydride, ethylene glycol-di(hydroper trimellitate), propylene glycol-di(dehydrated trimellitate), 1,4-butanediol - bis (dehydrated trimellitate), 1,6-hexanediol-di (anhydrotrimellitic acid ester), 1,8-octanediol-di (dehydrated trimellitate), 2, 2 - bis(4-hydroxyphenyl)propane-di(hydrogen trimellitate), a compound represented by the following formula (2) to (5), and the like. -21 - 200832019

,CH3 、ch3 (3), CH3, ch3 (3)

上述四羧酸二酐中,作爲脂環式四羧酸二酐,從能夠 使其表現良好的液晶配向性的角度出發,較佳爲1,2,3,4- -22- 200832019 環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二 酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環 戊烷四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、5-(2,5-二 氧代四氫呋喃亞甲基)-3-甲基-3-環己烯-1,2-二羧酸二酐、 順式-3,7 -二丁基環辛-1,5 -二烯-1,2,5,6 -四羧酸二酐、3,5,6 -三羰基-2-羧基降冰片烷-2:3,5:6-二酐、1,3,3&,4,5,9^六氫 -5-(四氫-2,5 -二氧代-3-呋喃基)-萘[l,2-c]呋喃-1,3 -二酮、 1,3,3&,4,5,91)-六氫-8-甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]呋喃-1,3-二酮、1,3,3&,4,5,91)-六氫-5,8-二甲基 -5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]呋喃-1,3-二酮、雙 環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐、3-氧雜雙環[3.2.1] 辛烷-2,4-二酮-6-螺-3’ -(四氫呋喃-2’ ,5’ -二酮)、5-(2,5- 二氧代四氫-3-呋喃基)-3-甲基-3-環己烯-1,2-二羧酸酐、 3,5,6-三羧基-2-羧基降冰片烷-2:3,5:6-二酐、4,9-二氧雜三 環[5.3.1.02’6]十一烷-3,5,8,10-四酮、上述式(I)表示的化合 物中的下述式(6)〜(8)表示的化合物或者上述式(II)表示的 化合物中的下述式(9)表示的化合物。 -23- 200832019Among the tetracarboxylic dianhydrides, alicyclic tetracarboxylic dianhydride is preferably 1,2,3,4--22-200832019 cyclobutane from the viewpoint of satisfactory liquid crystal alignment. Tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4 - cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cyclopentane tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 5-(2,5-di Oxotetrahydrofuran methylene)-3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride, cis-3,7-dibutylcyclooctane-1,5-diene-1 , 2,5,6-tetracarboxylic dianhydride, 3,5,6-tricarbonyl-2-carboxynorbornane-2:3,5:6-dianhydride, 1,3,3&,4,5 , 9^ hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]furan-1,3-dione, 1,3,3& 4,5,91)-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]furan-1,3-di Ketone, 1,3,3&,4,5,91)-hexahydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l ,2-c]furan-1,3-dione, bicyclo[2.2.2]-oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3-oxabicyclo[3.2.1 Octane-2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5'-dione), 5-(2,5-dioxotetrahydro-3-furanyl)- 3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 3,5,6-tricarboxy-2-carboxynorbornane-2:3,5:6-dianhydride, 4,9- Dioxatricyclo[5.3.1.0''6]undecane-3,5,8,10-tetraketone, a compound represented by the following formula (6) to (8) in the compound represented by the above formula (I) Or a compound represented by the following formula (9) in the compound represented by the above formula (II). -23- 200832019

i.i.

作爲特佳的,可以舉出1,2,3,4-環丁烷四羧酸二酐、1,3-二 甲基-1,2,3,4-環丁烷四羧酸二酐、2,3,5-三羧基環戊基醋酸 二酐、1,3,3&,4,5,913-六氫-5-(四氫-2,5-二氧代-3-呋喃基)-萘[1,2-叫呋喃-1,3-二酮、順式-3,7-二丁基環辛-1,5-二烯 -1,2,5,6-四羧酸二酐、3,5,6-三羰基-2-羧基降冰片烷 -2:3,5:6-二酐、1,3,3a,4,5,9b-六氫-8-甲基-5-(四氫-2,5-二氧 代-3-呋喃基)-萘[l,2-c]呋喃'1,3-二酮、3-氧雜雙環[3.2.1] 辛烷-2,4-二酮-6-螺-3’ -(四氫呋喃-2’ ,5’ ·二酮)、5-(2,5- -24- 200832019 二氧代四氫-3·呋喃基)-3-甲基-3-環己烯-1,2-:::竣酸肝、 3,5,6 -三羧基-2 -羧基降冰片烷-2 : 3,5 : 6 -二酐、4,9 ·二氧雜二 環[5.3.1.02,6]十一烷-3,5,8,10-四酮、和上述式(6)表示的化 合物,特佳爲2,3,5-三羧基環戊基醋酸二酐。 另外,作爲脂肪族四羧酸二酐和芳香族四羧酸二酐中 較佳的,可以舉出丁烷四羧酸二酐、均苯四酸二酐、 3,3’ ,4,4’ -二苯酮四羧酸二酐、3,3’ ,4,4’ -聯苯基颯四羧 酸二酐、2,2’ ,3,3’ -聯苯四羧酸二酐、1,4,5,8-萘四竣酸二 Γ I 酐。 這些.四羧酸二酐可以僅使用一種’也可以將兩種以上 混合使用。當僅使用一種時,較佳爲使用脂環式四羧酸二 酐,當將兩種以上混合使用時,較佳爲脂環式四羧酸二酐 的使用量相對於全部四羧酸二酐的使用量爲50莫耳%以 上。 作爲具有上述式(I - 1)表示的重複單元的聚醯胺酸的 合成中所用的二胺,可以舉出例如芳香族二胺、脂肪族或 ^ 者脂環式二胺〜分子內具有卩個丨級胺基和除了該丨級胺 基所含以外的氮原子的二胺、二胺基有機矽氧烷等。 作爲上述芳香族二胺,可以舉出例如對-苯二胺、間_ 苯二胺、4,4,-二胺基二苯基甲烷、4,4,-二胺基二苯基乙 烷、4,4,-二胺基二苯基硫醚、4,4,-二胺基二苯基颯、 2,2,-二甲基- 4,4,-二胺基聯苯、3,3,-二甲基_4,4’ -二胺 基聯苯、4,4,-二胺基苯甲醯苯胺、4,4,-二胺基二苯基 醚、1,5 -二胺基萘、2,2,-二三氟甲基- 4,4’ -二胺基聯本、 -25- 200832019 3,3’ -二三氟甲基-4,4’ -二胺基聯苯、5·胺基-1-(4’ -胺基 苯基)-1,3,3-三甲基茚滿、6-胺基-1-(4’ -胺基苯基)-1,3,3-三甲基茚滿、3,4’ -二胺基二苯基醚、3,3’ -二胺基二苯 酮、3,4’ -二胺基二苯酮、4,4’ -二胺基二苯酮、2,2·二[4-(4· 胺基苯氧基)苯基]丙烷、2,2-二[4-(4-胺基苯氧基)苯基]六氟 丙烷、2,2-二(4-胺基苯基)六氟丙烷、2,2-二[4-(4-胺基苯氧 基)苯基]楓、1,4-二(4-胺基苯氧基)苯、1,3-二(4-胺基苯氧 基)苯、1,3-二(3-胺基苯氧基)苯、9,9-二(4-胺基苯基M0- ί: 4 氫蒽、2,7-二胺基芴、9,9-二甲基-2,7-二胺基芴、9,9-二(4- 胺基苯基)芴、4,4’ -亞甲基-二(2-氯苯胺)、2,2’ ,5,5’ -四 氯-4,4’ -二胺基聯苯、2,2’ -二氯-4,4’ -二胺基- 5,5’ -二 甲氧基聯苯、3,3’ -二甲氧基-4,4’ -二胺基聯苯、 1,4,4’ -(對-伸苯基異亞丙基)二苯胺、4,4’ -(間-伸苯基異 亞丙基)二苯胺、2,2’ -二[4-(4-胺基-2-三氟甲基苯氧基)苯 基]六氟丙烷、4,4’ -二胺基-2,2’ -二(三氟甲基)聯苯、 4,4’ -二[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯等。 t 作爲上述脂肪族或脂環式二胺,可以舉出例如1,1 -間 苯二甲胺、1,3 -丙二胺、丁二胺、戊二胺、己二胺、庚二胺、 辛二胺、壬二胺、4,4-二胺基庚二胺、1,4-二胺基環己烷、 異佛爾酮二胺、四氫二環戊二烯二胺、六氫-4,7-甲撐茚二 亞甲基二胺、三環[6.2.1.02’7]-十一碳烯二甲二胺、4,4’ - 亞甲基二(環己胺)等。 作爲上述分子內具有2個1級胺基以及除了該1級胺 基所含以外的氮原子的二胺,可以舉出例如2,3 -二胺基吡 -26- 200832019 啶、2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嚼D定、 5.6- 二胺基-2,3-二氰基吡嗪、5,6-二胺基-2,4-二羥基嘧D定、 2,4-二胺基-6-二甲基胺基-1,3,5-三嗪、1,4-二(3-胺基丙基) 呱嗪、2,4-二胺基-6-異丙氧基-1,3,5 -三嗪、2,4-二胺基- 6-甲氧基-1,3,5-三嗪、2,4-二胺基-6-苯基-1,3,5-三曉、2,4-二 胺基-6-甲基-s-三嗪、2,4-二胺基·1,3,5-三嗪、4,6-二胺基_2-乙烯基-s-三嗪、2,4-二胺基-5-苯基噻唑、2,6-二胺基嘌哈、Particularly preferred are 1,2,3,4-cyclobutanetetracarboxylic dianhydride and 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride. 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 1,3,3&,4,5,913-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1,2-called furan-1,3-dione, cis-3,7-dibutylcyclooctane-1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 3 ,5,6-tricarbonyl-2-carboxynorbornane-2:3,5:6-dianhydride, 1,3,3a,4,5,9b-hexahydro-8-methyl-5-(four Hydrogen-2,5-dioxo-3-furanyl)-naphthalene[l,2-c]furan '1,3-diketone, 3-oxabicyclo[3.2.1]octane-2,4- Diketo-6-spiro-3'-(tetrahydrofuran-2',5'dione), 5-(2,5- -24-200832019 dioxotetrahydro-3.furanyl)-3-methyl 3-cyclohexene-1,2-::: citrate liver, 3,5,6-tricarboxy-2-carboxyl-norbornane-2: 3,5:6-dianhydride, 4,9 · two Oxabicyclo[5.3.1.02,6]undecane-3,5,8,10-tetraketone, and a compound represented by the above formula (6), particularly preferably 2,3,5-tricarboxycyclopentyl Acetic acid dianhydride. Further, preferred examples of the aliphatic tetracarboxylic dianhydride and the aromatic tetracarboxylic dianhydride include butane tetracarboxylic dianhydride, pyromellitic dianhydride, and 3,3', 4, 4'. - benzophenone tetracarboxylic dianhydride, 3,3',4,4'-biphenylindole tetracarboxylic dianhydride, 2,2',3,3'-biphenyltetracarboxylic dianhydride, 1, 4,5,8-naphthotetradecanoate dioxime I anhydride. These tetracarboxylic dianhydrides may be used singly or in combination of two or more. When only one type is used, it is preferred to use an alicyclic tetracarboxylic dianhydride. When two or more types are used in combination, the alicyclic tetracarboxylic dianhydride is preferably used in an amount relative to the entire tetracarboxylic dianhydride. The amount used is 50% by mole or more. The diamine used in the synthesis of the polyamic acid having the repeating unit represented by the above formula (I-1) may, for example, be an aromatic diamine, an aliphatic or an alicyclic diamine. A hydrazine-based amine group and a diamine, a diamine-based organoaluminoxane or the like in addition to a nitrogen atom other than the hydrazine-based amine group. Examples of the aromatic diamine include p-phenylenediamine, m-phenylenediamine, 4,4,-diaminodiphenylmethane, and 4,4,-diaminodiphenylethane. 4,4,-Diaminodiphenyl sulfide, 4,4,-diaminodiphenylanthracene, 2,2,-dimethyl-4,4,-diaminobiphenyl, 3,3 ,-Dimethyl-4,4'-diaminobiphenyl, 4,4,-diaminobenzimidamide, 4,4,-diaminodiphenyl ether, 1,5-diamino Naphthalene, 2,2,-ditrifluoromethyl-4,4'-diamino-based, -25- 200832019 3,3'-ditrifluoromethyl-4,4'-diaminobiphenyl, 5. Amino-1-(4'-aminophenyl)-1,3,3-trimethylindan, 6-amino-1-(4'-aminophenyl)-1,3, 3-trimethylindan, 3,4'-diaminodiphenyl ether, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 4,4' - Diaminobenzophenone, 2,2·bis[4-(4·aminophenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexa Fluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl] maple, 1,4-di(4- Aminophenoxy)benzene, 1,3-bis(4-aminophenoxyl) Benzo, 1,3-bis(3-aminophenoxy)benzene, 9,9-bis(4-aminophenyl M0- ί: 4 hydroquinone, 2,7-diamino fluorene, 9 , 9-dimethyl-2,7-diaminopurine, 9,9-bis(4-aminophenyl)anthracene, 4,4'-methylene-bis(2-chloroaniline), 2, 2',5,5'-tetrachloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diamino- 5,5'-dimethoxybiphenyl , 3,3'-dimethoxy-4,4'-diaminobiphenyl, 1,4,4'-(p-phenylphenylisopropylene)diphenylamine, 4,4'- -phenylphenylisopropylene)diphenylamine, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4'-di Amino-2,2'-bis(trifluoromethyl)biphenyl, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl, etc. Examples of the aliphatic or alicyclic diamine include 1,1-m-xylylenediamine, 1,3-propylenediamine, butanediamine, pentamethylenediamine, hexamethylenediamine, heptanediamine, and octane. Diamine, decane diamine, 4,4-diaminoheptyldiamine, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadiene diamine, hexahydro-4 ,7-methylene dimethylene Diamine, tricyclo[6.2.1.02'7]-undecene dimethyldiamine, 4,4'-methylenebis(cyclohexylamine), etc. as the above-mentioned molecule having two first-order amine groups and Examples of the diamine of a nitrogen atom other than the amine group of the first-stage amine group include, for example, 2,3-diaminopyridin-26-200832019 pyridine, 2,6-diaminopyridine, and 3,4-diamino group. Pyridine, 2,4-diamine-based chelate D, 5.6-diamino-2,3-dicyanopyrazine, 5,6-diamino-2,4-dihydroxypyrimidine D, 2,4 -diamino-6-dimethylamino-1,3,5-triazine, 1,4-bis(3-aminopropyl)pyridazine, 2,4-diamino-6-isopropyl Oxy-1,3,5-triazine, 2,4-diamino-6-methoxy-1,3,5-triazine, 2,4-diamino-6-phenyl-1, 3,5-trisyl, 2,4-diamino-6-methyl-s-triazine, 2,4-diamino-1,3,5-triazine, 4,6-diamino 2-vinyl-s-triazine, 2,4-diamino-5-phenylthiazole, 2,6-diamine-based hip-hop,

5.6- 二胺基-1,3-二甲基尿嘧啶、3,5-二胺基-1,2,4-三唑、6,9- 二胺基-2 -乙氧基Π丫 Β定乳酸酯、3 , 8 -二胺基-6 -苯基菲d定、1,4 _ 二胺基呱嗪、3,6-二胺基吖啶、二(4-胺基苯基)苯基胺、3,6_ 二胺基咔唑、Ν-甲基-3,6-二胺基咔唑、Ν-乙基_3,6-二胺基 昨卩坐、]\1-苯基-3,6-二胺基昨哇、;^,^[’-二(4-胺基苯基)-聯 苯胺、Ν,Ν’ -二(4-胺基苯基)·Ν,Ν’ ·二甲基-聯苯胺等。 另外,作爲上述二胺基有機矽氧烷,可以舉出下述式 (1 0)表不的化合物等, R21 R21 (10) H2N-fCH2^-卞个姑 CH 七 ΝΗ2 R21 R21 (式中,R21表示碳數爲1〜12的烴基’複數個存在的 R21各自可以相同也可以不同,Ρ爲1〜3的整數,q爲1〜 2 0的整數)。 這些二胺可以僅使用1種,也可以將2種以上組合使 用。 這些二胺中,較佳爲對-苯二胺、4,4’ -二胺基二苯甲 -27- 200832019 烷、4,4’ -二胺基二苯硫醚、2,2’ -二甲基_4,4’ -二胺基聯 苯、1,5-二胺基萘、2,7-二胺基芴、9,9-二甲基- 2,7-二胺基 芴、4,4’ -二胺基二苯醚、2,2-二[4-(4-胺基苯氧基)苯基] 丙烷、9,9-二(4-胺基苯基)芴、2,2-二[4-(4-胺基苯氧基)苯 基]六氟丙烷、2,2-二(4-胺基苯基)六氟丙烷、4,4’ -(對-伸 苯基二異亞丙基)二苯胺、4,4’ -(間-伸苯基二異亞丙基)二5.6-Diamino-1,3-dimethyluracil, 3,5-diamino-1,2,4-triazole, 6,9-diamino-2-ethoxylated Lactic acid ester, 3,8-diamino-6-phenylphenanthrene, 1,4-diaminopyridazine, 3,6-diaminoacridine, bis(4-aminophenyl)benzene Amine, 3,6-diaminocarbazole, oxime-methyl-3,6-diaminocarbazole, oxime-ethyl-3,6-diamine, squat,]\1-phenyl- 3,6-Diamino, yesterday, ^, ^^['-bis(4-aminophenyl)-benzidine, anthracene, Ν'-bis(4-aminophenyl)·Ν,Ν' Dimethyl-benzidine, etc. In addition, as the above-mentioned diamine organooxane, a compound represented by the following formula (10), and the like, R21 R21 (10) H2N-fCH2^-卞 姑CH ΝΗ7ΝΗ2 R21 R21 (wherein R21 represents a hydrocarbon group having 1 to 12 carbon atoms. A plurality of R21 groups may be the same or different, and Ρ is an integer of 1 to 3, and q is an integer of 1 to 2 0). These diamines may be used alone or in combination of two or more. Among these diamines, p-phenylenediamine, 4,4'-diaminodiphenyl-27-200832019 alkane, 4,4'-diaminodiphenyl sulfide, 2,2'-di are preferred. Methyl 4,4'-diaminobiphenyl, 1,5-diaminonaphthalene, 2,7-diaminopurine, 9,9-dimethyl-2,7-diaminopurine, 4 , 4'-diaminodiphenyl ether, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 9,9-bis(4-aminophenyl)anthracene, 2, 2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4'-(p-phenylene) Diisopropylidene)diphenylamine, 4,4'-(m-phenylene diisopropylidene)

苯胺、1,4-環己烷二胺、4,4’ -亞甲基二(環己胺)、1,4-二(4_ 胺基苯氧基)苯、4,4’ -二(4-胺基苯氧基)聯苯、2,6-二胺基 吡啶、3,4 -二胺基吡啶、2,4 -二胺基嘧啶、3,6 -二胺基吖啶、 3,6 -二胺基咔唑、N -甲基-3,6 -二胺基咔唑、N -乙基-3,6 -二 胺基咔唑、N-苯基-3,6-二胺基咔唑、N,N’ -二(4-胺基苯基)-聯苯胺、N,N’ -二(4-胺基苯基)-Ν,Ν’ -二甲基-聯苯胺。 在使本發明液晶配向劑具有預傾角表現性能時,較佳 爲具有上述式(I - 1)表示的重複單元的聚醯胺酸之合成中 所用的二胺一部分或者全部爲具有下述式(Q - 1)或下述式 (Q — 2)表示的結構的二胺(以下,稱爲“特定二胺”),Aniline, 1,4-cyclohexanediamine, 4,4'-methylenebis(cyclohexylamine), 1,4-bis(4-aminophenoxy)benzene, 4,4'-di (4 -aminophenoxy)biphenyl, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminoacridine, 3,6 -diaminocarbazole, N-methyl-3,6-diaminocarbazole, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminoguanidine Azole, N,N'-bis(4-aminophenyl)-benzidine, N,N'-bis(4-aminophenyl)-indole, Ν'-dimethyl-benzidine. When the liquid crystal alignment agent of the present invention has a pretilt performance performance, it is preferred that a part or all of the diamine used in the synthesis of the polyamic acid having the repeating unit represented by the above formula (I-1) has the following formula ( Q - 1) or a diamine of the structure represented by the following formula (Q-2) (hereinafter, referred to as "specific diamine"),

(Q-1) (式中,Ζ爲單鍵、-〇-、-C〇-、-C〇〇-、-〇C〇-、-NHCO-、 -C〇NH-、-S-或伸芳基,R19是碳數爲10〜20的烷基、碳數 爲4〜40的具有脂環式骨架的1價有機基團或者碳數爲6 〜20的含氟原子的1價有機基團), -28- 200832019 Z————z(Q-1) (wherein, Ζ is a single bond, -〇-, -C〇-, -C〇〇-, -〇C〇-, -NHCO-, -C〇NH-, -S- or An aryl group, R19 is an alkyl group having a carbon number of 10 to 20, a monovalent organic group having an alicyclic skeleton having a carbon number of 4 to 40, or a fluorine-containing monovalent organic group having a carbon number of 6 to 20. ), -28- 200832019 Z————z

(Q-2) (式中,Z 爲單鍵、-〇-、-CO-、-C〇〇-、-〇C〇-、-NHC〇-、 -C〇NH-、-S-或伸芳基,R2°是碳數爲4〜40的具有脂環式 骨架的2價有機基團)。這樣,可以使上述式(1 一 1)中的基 團Q1和基團Q2的一部分或全部爲上述式(Q — Π或(Q— 2) 表示的結構的基團,從而使其具有表現預傾角的性能。 上述式(Q — 1)中,作爲R19表示的碳數爲丨0〜20的院 基,可以舉出例如正癸基、正十二烷基、正十五烷基、正 十六院基、正十八院基、正二十院基等。另外’作爲上述 式(Q — 1)中的R19和上述式(Q— 2)中的R2°表示的碳數爲4 〜40的具有脂環式骨架的有機基團,可以舉出例如具有來 源於環丁烷、環戊烷、環己烷、環癸烷等環烷的脂環式骨 架的基團;具有膽甾醇、膽甾烷醇等甾體骨架的基團;具 有降冰片烯、金剛烷等有橋脂環式骨架的基團等。其中, 特佳爲具有甾體骨架的基團。具有上述脂環式骨架的有機 基團還可以是被鹵素原子(較佳爲氟原子)或者氟代烷基(較 佳爲三氟甲基)取代的基團。 此外,作爲上述式(Q — 1)中的R19表示的碳數爲6〜20 的含氟原子的基團,可以舉出例如正己基、正辛基、正癸 基寺fe數爲6以上的直鍵院基;環己基、環辛基等碳數爲 6以上的脂環式烴基;苯基、聯苯基等碳數爲6以上的芳 香族烴基等有機基團的氫原子一部分或全部被氟原子或三 -29- 200832019 氯甲基%氯代院基取代的基團。 另外,上述式(Q—1)和上述式(Q— 2)中的Z爲單鍵、 -〇-、-C〇-、-COO- ' -〇C〇-、-NHC〇-、-C〇NH-、-S_ 或者伸 芳基,作爲伸芳基,可以舉出伸苯基、伸甲苯基、伸聯苯 基、伸萘基等。 作爲具有上述式(Q - 1 )表示的結構的二胺的具體例 子,可以舉出例如十二烷氧基-2,4-二胺基苯、十五烷氧基 -2,4·二胺基苯、十六烷氧基-2,4-二胺基苯、十八烷氧基-2,4-二胺基苯、下述式(11)〜(15)表示的化合物等。(Q-2) (wherein Z is a single bond, -〇-, -CO-, -C〇〇-, -〇C〇-, -NHC〇-, -C〇NH-, -S- or The aryl group, R2° is a divalent organic group having an alicyclic skeleton having a carbon number of 4 to 40). Thus, a part or all of the group Q1 and the group Q2 in the above formula (1 - 1) can be a group of the structure represented by the above formula (Q - Π or (Q - 2), thereby giving it a performance pre In the above formula (Q-1), the group having a carbon number of 丨0 to 20 represented by R19 may, for example, be n-decyl, n-dodecyl, n-pentadecyl or n. The six-yard base, the positive eight-yard base, the positive ten-yard base, etc. In addition, the carbon number represented by R19 in the above formula (Q-1) and R2° in the above formula (Q-2) is 4 to 40. The organic group having an alicyclic skeleton may, for example, be a group having an alicyclic skeleton derived from a cycloalkane such as cyclobutane, cyclopentane, cyclohexane or cyclodecane; having cholesteric and cholesteric a group having a steroid skeleton such as decyl alcohol; a group having a bridged alicyclic skeleton such as norbornene or adamantane; and particularly preferably a group having a steroid skeleton. The organic group may also be a group substituted by a halogen atom (preferably a fluorine atom) or a fluoroalkyl group (preferably a trifluoromethyl group). The fluorine atom-containing group having 6 to 20 carbon atoms represented by R19 in the above formula (Q-1) may, for example, be a straight bond of n-hexyl, n-octyl or n-decyl group having a number of 6 or more. An alicyclic hydrocarbon group having 6 or more carbon atoms such as a cyclohexyl group or a cyclooctyl group; and a hydrogen atom of an organic group such as an aromatic hydrocarbon group having 6 or more carbon atoms such as a phenyl group or a biphenyl group; Or three -29- 200832019 chloromethyl% chlorophenyl group-substituted groups. In addition, Z in the above formula (Q-1) and the above formula (Q-2) is a single bond, -〇-, -C〇 -, -COO- ' -〇C〇-, -NHC〇-, -C〇NH-, -S_ or an aryl group. Examples of the aryl group include a phenyl group, a tolyl group, and a phenyl group. Further, as a specific example of the diamine having a structure represented by the above formula (Q-1), for example, dodecyloxy-2,4-diaminobenzene or pentadecyloxy group can be mentioned. 2,4·diaminobenzene, hexadecyloxy-2,4-diaminobenzene, octadecyloxy-2,4-diaminobenzene, represented by the following formulas (11) to (15) Compounds, etc.

30- 200832019 作爲具有上述式(Q - 2)表示的結構的二胺的具體例 子’可以舉出例如下述式(16)〜(18)表示的化合物等。這些 特定二胺可以僅使用1種,或者將2種以上組合使用。30-200832019 Specific examples of the diamine having a structure represented by the above formula (Q-2) include, for example, a compound represented by the following formulas (16) to (18). These specific diamines may be used alone or in combination of two or more.

這些特定二胺中,較佳爲上述式(11)、(13)、(15)或(16) 表示的化合物。 特定二胺相對於全部二胺量的使用比率,隨著所要使 其表現的預傾角的大小而不同,對於TN型、STN型液晶顯 示元件的情況,較佳爲〇〜5莫耳%,對於垂直配向型液晶 顯示元件的情況,較佳爲5〜1 00莫耳%。 相對於供給具有上述式(I - 1)表示的重複單元的聚醯 胺酸的合成之二胺的1當量胺基’四羧酸二酐的酸酐基較 佳爲0.2〜2當量的比率’更佳爲0 · 3〜1 · 2當量的比率。 聚醯胺酸的合成反應,在有機溶劑中,較佳爲於-20°C 〜150 °C,更佳爲於〇〜1〇〇 °C的溫度條件下,較佳爲進行 -31 - 200832019 1 0分鐘〜5 0小時,更佳爲進行3 0分鐘〜3 0小時。 這裏,作爲有機溶劑,只要能夠溶解合成的聚醯胺酸, 則對其沒有特別的限制,可以例示例如1 -甲基-2 -吡咯烷 酮、Ν,Ν-二甲基乙醯胺、Ν,Ν-二甲基甲醯胺、3-丁氧基- Ν,Ν-二甲基丙醯胺、3-甲氧基- Ν,Ν-二甲基丙醯胺、3-己基氧基 -Ν,Ν-二甲基丙醯胺等醯胺類溶劑;二甲基亞颯、r、丁內 酯、四甲基脲、六甲基磷醯三胺等非質子類極性溶劑;間-^ 曱基酚、二甲苯酚、苯酚、鹵代苯酚等酚類溶劑。 Γ 有機溶劑的用量(^ )通常較佳爲使四羧酸二酐和二胺 化合物的總量(/3 )相對於反應溶液的總量(α + /3 )爲〇. 1〜 3 0重量%的量。 在不使生成的聚醯胺酸析出的範圍內,如上所述的有 機溶劑的一部分還可以用聚醯胺酸的不良溶劑(poor sol vent)醇類、酮類、酯類、醚類、鹵代烴類、烴類等替代。 作爲這種不良溶劑的具體例子,可以舉出例如甲醇、乙醇、 異丙醇、環己醇、4 -羥基-4-甲基-2-戊酮、乙二醇、丙二醇、 1,4 - 丁二醇、三甘醇、乙二醇單甲基醚、乳酸乙酯、乳酸丁 酯、丙酮、甲基乙基酮、甲基異丁基酮、環己酮、醋酸甲 酯、醋酸乙酯、醋酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸 乙酯、草酸二乙酯、丙二酸二乙酯、二乙基醚、乙二醇甲 基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、 乙二醇正丁基醚、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、 二甘醇二甲基醚、二甘醇二乙基醚、二甘醇單甲基醚、二 甘醇單乙基醚、二甘醇單甲基醚乙酸酯、二甘醇單乙基醚 -32- 200832019 乙酸酯、四氫呋喃、二氯甲烷、1,2-二氯乙烷、1,4-二氯丁 烷、三氯乙烷、氯苯、鄰二氯苯、己烷、庚烷、辛烷、苯、 甲苯、二甲苯、丙酸異戊酯、異丁酸異戊酯、二異戊基醚 等。 這裏可以使用的不良溶劑的用量,在全部溶劑中較佳 爲50重量%以下,更佳爲40重量%以下。 如上所述,得到溶解了聚醯胺酸的反應溶液。然後’ 將該反應溶液投入到大量的不良溶劑中,獲得析出物’能 通過減壓下乾燥該析出物或用蒸發器將反應溶液減壓餾出 而獲得聚醯胺酸。並且,將該聚醯胺酸再次溶解於有機溶 劑中,然後通過進行一次或者數次用不良溶劑使其析出之 製程,或用蒸發器減壓餾出之製程,可以精製聚醯胺酸。 具有上述式(I - 2)表示的重複單元的聚醯亞胺可以通 過將具有上述式(I —丨)中p1爲p2、Q1爲Q2的重複單元的聚 醯胺酸脫水閉環而製得。 在脫水閉環時,可以使醯胺酸結構全部脫水閉環形成 醯亞胺環,也可以僅使醯胺酸結構一部分脫水閉環形成醯 胺酸結構與醯亞胺環結構共存的聚合物。作爲可用於本發 明的聚醯亞胺,相對於全部重複單元,具有醯亞胺環的重 複單元的比率(以下,稱爲“醯亞胺化率”)較佳爲40莫耳 %以上,更佳爲50莫耳%以上。通過使用醯亞胺化率爲40 莫耳%以上的聚合物,可以獲得能夠形成殘像消除時間短的 液晶配向fl吴的液晶配向劑。醯亞胺化率可以由下述方法而 求出。 -33- 200832019 醯亞胺化聚合物的醯亞胺化率測定H 能將醯亞胺化聚合物在室溫下減壓乾燥後, - 代二甲基亞楓中,以四甲基矽烷爲基準物質,在 行1H-NMR測定,以下述(ii)表示的公式求得。 醯亞胺化率(%) = (1— AVA2xa )xl〇〇—--- A1 :來源於NH基的質子的峰値面積(i〇ppm) A2 :來源於其他的質子的峰値面積 , α :聚合物的前驅物(聚醯胺酸)中,相對於1 的質子之其他質子的個數比例。 聚醯胺酸的脫水閉環可以(i)通過加熱聚醯^ 法,或者(ii)通過將聚醯胺酸溶解於有機溶劑中, 中加入脫水劑和脫水閉環催化劑並根據需要加熱 進行。 上述(i)的加熱聚醯胺酸的方法中的反應溫度 50〜200 °C,更佳爲60〜170 °C。當反應溫度不足 則脫水閉環反應不能進行完全,如果反應溫度超3 則會出現所得醯亞胺化聚合物的分子量下降的情 時間較佳爲1 0分鐘〜5小時,更佳爲3 0分鐘〜3 另一方面,對於在上述(ii)的在聚醯胺酸溶液 水劑和脫水閉環催化劑的方法的情況,作爲脫水 使用例如醋酸酐、丙酸酐、三氟乙酸酐等酸酐。 用量,根據所需醯亞胺化率而定,較佳爲相對於 醯胺酸的重複單元,爲0.0 1〜2 0莫耳。作爲脫水 劑,可以使用例如吡啶、三甲基吡啶、二甲基口比 溶解在氘 室溫下進 ——(ii) 個NH基 胺酸的方 向該溶液 的方法而 ,較佳爲 5 0〇C 時, ® 200。。, 況。反應 小時。 中添加脫 劑,可以 脫水劑的 1莫耳聚 閉環催化 啶、三乙 -34- 200832019 基fee等3級胺。但是,並不局限於這些。脫水閉環催化劑 的用量,相對於1莫耳所用脫水劑,較佳爲〇 . 〇丨〜1 〇莫耳。 上述脫水劑、脫水閉環催化劑的用量越多,則可使醯亞胺 化率越高。此外,作爲脫水閉環反應中使用的有機溶劑, 可以舉出作爲聚醯胺酸合成中所用溶劑而例示的有機溶 劑。並且,脫水閉環反應的反應溫度較佳爲〇〜1 8 〇 °C,更 佳爲1 0〜1 5 0 °C。反應時間較佳爲3 0分鐘〜1 0小時,更佳 r 爲1小時〜7小時。 通過對如此得到的反應溶液進行與聚醯胺酸之精製方 法中同樣的操作,可以精製所得之聚醯亞胺。 具有上述式(I - 1)表示的重複單元的聚醯胺酸或者具 有上述式(I - 2)表示的重複單元的聚醯亞胺還可以是進行 了分子量調節的末端修飾型聚合物。通過使用該末端修飾 型聚醯胺酸或聚醯亞胺,可以在不損害本發明效果的前提 下改善液晶配向劑的塗敷特性等。這種末端修飾型之聚醯 胺酸或聚醯亞胺可以通過在合成聚醯胺酸時,向反應體系 中加入一元酸酐、單胺化合物、單異氰酸酯化合物等而合 成。其中,作爲一元酸酐,可以舉出例如馬來酸酐、苯二 甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸 酐、正十四烷基琥珀酸酐、正十六烷基琥珀酸酐等。此外, 作爲單胺化合物,可以舉出例如苯胺、環己胺、正丁胺、 正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正 十一烷胺、正十二烷胺、正十三烷胺、正十四烷胺、正十 五烷胺、正十六烷胺、正十七烷胺、正十八烷胺、正二十 -35- 200832019 烷胺等。此外,作爲單異氰酸酯化合物,可以 氰酸苯酯、異氰酸萘基酯等。Among these specific diamines, preferred are the compounds represented by the above formula (11), (13), (15) or (16). The ratio of use of the specific diamine to the total amount of the diamine varies depending on the magnitude of the pretilt angle to be expressed, and in the case of the TN type or STN type liquid crystal display element, it is preferably 〇5 to 5 mol%. In the case of the vertical alignment type liquid crystal display element, it is preferably 5 to 100% by mole. The acid anhydride group of one equivalent of the amine-tetracarboxylic dianhydride of the synthetic diamine to which the polyaminic acid having the repeating unit represented by the above formula (I-1) is supplied is preferably a ratio of 0.2 to 2 equivalents. Good for 0 · 3 ~ 1 · 2 equivalent ratio. The synthesis reaction of polylysine is preferably carried out in an organic solvent at -20 ° C to 150 ° C, more preferably at a temperature of 〇 1 ° ° C, preferably -31 - 200832019 1 0 minutes ~ 5 0 hours, more preferably for 30 minutes ~ 3 0 hours. Here, the organic solvent is not particularly limited as long as it can dissolve the synthesized polyamic acid, and examples thereof include 1-methyl-2-pyrrolidone, anthracene, fluorene-dimethylacetamide, hydrazine, and hydrazine. - dimethylformamide, 3-butoxy-oxime, Ν-dimethylpropanamide, 3-methoxy-oxime, Ν-dimethylpropanamine, 3-hexyloxy-oxime, Amidoxime solvent such as hydrazine-dimethylpropionamide; aprotic polar solvent such as dimethyl hydrazine, r, butyrolactone, tetramethylurea or hexamethylphosphonium triamine; A phenolic solvent such as phenol, xylenol, phenol or halogenated phenol. The amount of the organic solvent (^) is usually preferably such that the total amount of the tetracarboxylic dianhydride and the diamine compound (/3) is 〇. 1 to 30 by weight relative to the total amount of the reaction solution (α + /3 ). The amount of %. In the range in which the produced polyamine acid is not precipitated, a part of the organic solvent as described above may also be a poor solvent of polylysine, an alcohol, a ketone, an ester, an ether, or a halogen. Replacement of hydrocarbons, hydrocarbons, etc. Specific examples of such a poor solvent include methanol, ethanol, isopropanol, cyclohexanol, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol, propylene glycol, and 1,4 - Glycol, triethylene glycol, ethylene glycol monomethyl ether, ethyl lactate, butyl lactate, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, methyl acetate, ethyl acetate, Butyl acetate, methyl methoxypropionate, ethyl ethoxypropionate, diethyl oxalate, diethyl malonate, diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether , ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, two Glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether-32- 200832019 acetate, tetrahydrofuran , dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, o-dichlorobenzene, hexane, heptane, octane, benzene, toluene, two Toluene, isoamyl propionate, isobutyric acid Amyl, diisoamyl ether. The amount of the poor solvent which can be used herein is preferably 50% by weight or less, more preferably 40% by weight or less, based on the total amount of the solvent. As described above, a reaction solution in which polylysine was dissolved was obtained. Then, the reaction solution is poured into a large amount of a poor solvent to obtain a precipitate, and the precipitate can be dried under reduced pressure or the reaction solution can be distilled off under reduced pressure with an evaporator to obtain a polyamine. Further, the polyproline is re-dissolved in the organic solvent, and then the polyamine acid can be purified by a process of precipitating with a poor solvent once or several times or by distillation under reduced pressure using an evaporator. The polyimine having the repeating unit represented by the above formula (I-2) can be obtained by dehydrating and ring-closing polylysine having a repeating unit of the above formula (I-丨) wherein p1 is p2 and Q1 is Q2. In the case of dehydration ring closure, the proline structure may be dehydrated and closed to form a quinone ring, or only a part of the proline structure may be dehydrated and closed to form a polymer having a guanidine structure and a quinone ring structure. As the polyimine which can be used in the present invention, the ratio of the repeating unit having a quinone ring (hereinafter referred to as "deuterated imidization ratio") is preferably 40 mol% or more with respect to all the repeating units. Good is 50% or more. By using a polymer having a ruthenium iodide ratio of 40 mol% or more, a liquid crystal alignment agent capable of forming a liquid crystal alignment flue having a short afterimage erasing time can be obtained. The ruthenium amination rate can be determined by the following method. -33- 200832019 Determination of oxime imidization ratio of ruthenium iodide H After drying the ruthenium iodide polymer under reduced pressure at room temperature, in the case of dimethyl sulfoxide, tetramethyl decane The reference material was determined by 1H-NMR and determined by the formula shown in the following (ii). Ruthenium amination rate (%) = (1 - AVA2xa)xl〇〇---- A1 : peak area of protons derived from NH group (i〇ppm) A2 : peak area derived from other protons, α : ratio of the number of other protons of protons of 1 in the precursor of the polymer (polyproline). The dehydration ring closure of polylysine may be carried out by (i) heating by a polyhydrazine method, or (ii) by dissolving polyglycine in an organic solvent, adding a dehydrating agent and a dehydration ring-closure catalyst, and heating as needed. The reaction temperature in the above method (i) for heating poly-proline is 50 to 200 ° C, more preferably 60 to 170 ° C. When the reaction temperature is insufficient, the dehydration ring-closure reaction cannot be completed completely. If the reaction temperature exceeds 3, the molecular weight of the obtained ruthenium-imided polymer is preferably decreased from 10 minutes to 5 hours, more preferably 30 minutes. 3 On the other hand, in the case of the method of the above polychlorinated acid solution and the dehydration ring-closure catalyst in the above (ii), an acid anhydride such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride is used as the dehydration. The amount, depending on the desired hydrazine imidization ratio, is preferably 0.01 to 2 moles relative to the repeating unit of valine. As the dehydrating agent, for example, a method in which pyridine, trimethylpyridine, or dimethyl port is dissolved in the direction of (ii) NH-amino acid at room temperature is preferably used, and preferably 50 Å. C, ® 200. . , condition. The reaction is small. A de-agent can be added, and the dehydrogenating agent can be catalyzed by a 1 molar polymerization ring-blocking catalyst such as pyridine or triethyl-34-200832019-based fee. However, it is not limited to these. The amount of the dehydration ring-closing catalyst is preferably 〇 1 1 1 1 1 相对 relative to the dehydrating agent used in 1 mol. The higher the amount of the above dehydrating agent and the dehydration ring-closing catalyst, the higher the ruthenium amination rate. Further, as the organic solvent used in the dehydration ring-closure reaction, an organic solvent exemplified as a solvent used in the synthesis of polylysine may be mentioned. Further, the reaction temperature of the dehydration ring closure reaction is preferably 〇~1 8 〇 ° C, more preferably 10 0 to 150 ° C. The reaction time is preferably from 30 minutes to 10 hours, more preferably from 1 hour to 7 hours. The obtained polyimine can be purified by subjecting the reaction solution thus obtained to the same operation as in the purification method of polylysine. The polyaminic acid having the repeating unit represented by the above formula (I-1) or the polyimine having the repeating unit represented by the above formula (I-2) may also be a terminal-modified polymer having a molecular weight adjusted. By using the terminal-modified polyglycolic acid or polyimine, the coating properties and the like of the liquid crystal alignment agent can be improved without impairing the effects of the present invention. Such a terminally modified polyamic acid or polyimine can be synthesized by adding a monobasic acid anhydride, a monoamine compound, a monoisocyanate compound or the like to the reaction system in the synthesis of polyamic acid. Among them, examples of the monobasic acid anhydride include maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl succinic anhydride, n-hexadecyl group. Succinic anhydride and the like. Further, examples of the monoamine compound include aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-decylamine, n-decylamine, n-undecylamine, and the like. N-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecaneamine, n-octadecylamine, n-t-35-200832019 Amines, etc. Further, as the monoisocyanate compound, phenyl cyanate or naphthyl isocyanate may be used.

如上所得的具有上述式(I - 1)表示的重複 胺酸或具有上述式(I - 2)表示的重複單元的聚 10%的溶液的情況下,較佳爲具有20〜800mPa 合物,更佳爲具有30〜5 00mPa.s黏度的聚合物 另外,聚合物的溶液黏度(mPa’s),使用指 對於稀釋到10%的固體成分濃度的溶液,用E Γ 計在25 °C下測定。 當本發明的液晶配向劑爲含有具有上述式 的重複單元的聚醯胺酸或具有上述式(I - 2)表 元的聚醯亞胺時,其使用比率,對於第一液晶 對於1重量份上述式(1)表示的化合物,較佳爲 以下,更佳爲10〜500重量份。另外,對於第 劑,相對於1重量份由上述通式(1 ’ )表示的化 & 酸二酐反應所得的聚醯胺酸,較佳爲1 00重量 佳爲5〜80重量份。 本發明的液晶配向劑較佳爲同時含有具有 1)表示的重複單元的聚醯胺酸和具有上述式(] 重複單元的聚醯亞胺兩者。這時,具有上述式( 重複單元的聚醯胺酸和具有上述式(I - 2)表示 的聚醯亞胺的合計使用量較佳爲在上述範圍內 爲具有上述式(I 一 1)表示的重複單元的聚醯胺 述式(I - 2)表示的重複單元的聚醯亞胺的使用t 舉出例如異 單元的聚醯 醯亞胺,在 •s黏度的聚 〇 定的溶劑, 型旋轉黏度 :(I 一 1)表示 示的重複單 配向劑,相 1 0 0 0重量份 一液晶配向 合物與四羧 份以下,更 上述式(I 一 t 一 2 )袠示的 1 一 1)表示的 的重複單元 。另外,作 酸和具有上 :匕率,相對於 -36 - 200832019 具有上述式(I 一 1)表示的重複單元的聚醋胺酸與具有上述 式(I - 2)表示的重複單元的聚醯亞胺的合計量,具有上述式 (I - 1)表示的重複單元的聚醯胺酸使用量較佳爲50〜95重 量%,更佳爲55〜90重量%。 具有上述式(I - 1)表示的重複單元的聚醯胺酸和具有 上述式(I - 2)表示的重複單元的聚醯亞胺,均較佳爲由包含 2,3,5-三羧基環戊基醋酸二酐的四羧酸二酐與二胺合成的 聚合物。在此情況下,2,3,5-三羧基環戊基醋酸二酐的用量 相對於全部四羧酸二酐的用量,較佳爲50莫耳%以上。 作爲上述接著性提升劑,可以舉出例如含官能性矽烷 的化合物、式(1)或式(1’ )表示的化合物以外的環氧化合物 等。 作爲上述含官能性矽烷化合物,可以舉出例如3 -胺基 丙基三甲氧基矽烷、3 -胺基丙基三乙氧基矽烷、2 -胺基丙 基二甲氧基砂院、2 -胺基丙基三乙氧基砂院、Ν-(2·胺基乙 基)_3-胺基丙基三甲氧基矽烷、Ν-(2-胺基乙基)-3-胺基丙基 甲基二甲氧基矽烷、3 -脲基丙基三甲氧基矽烷、3 -脲基丙 基三乙氧基矽烷、N -乙氧羰基-3-胺基丙基三甲氧基矽烷、 N-乙氧羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基 丙基三伸乙基三胺、N-三甲氧基矽烷基丙基三伸乙基三 胺、1 0 -三甲氧基矽烷基-1,4,7 -三氮雜癸烷、1 〇 -三乙氧基矽 烷基-1,4,7 -三氮雜癸烷、9 -三甲氧基矽烷基-3,6 -二氮雜壬 基乙酸酯、9-三乙氧基矽烷基-3,6-二氮雜壬基乙酸酯、N-苄基-3-胺基丙基三甲氧基矽烷、N_苄基-3-胺基丙基三乙氧 -37- 200832019 基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯 丙基三乙氧基矽烷、N -二(氧乙烯基)-3 -胺基丙基 矽烷、N-二(氧乙烯基)-3-胺基丙基三乙氧基矽烷 作爲式(1)或式(1 ’)表示的化合物以外的 物,可以舉出例如乙二醇二縮水甘油醚、聚乙二 甘油醚、丙二醇二縮水甘油醚、三丙二醇二縮水 聚丙二醇二縮水甘油醚、新戊二醇二縮水甘油醚 醇二縮水甘油醚、甘油二縮水甘油醚、2,2 -二溴新 縮水甘油醚、1,3,5,6-四縮水甘油基-2,4- E N,N,N’ ,N’ -四縮水甘油基間·苯二甲胺、1,3-二 水甘油基胺基甲基)環己烷、N,N,N’ ,N’ -四縮 -4,4’ -二胺基二苯基甲烷、N,N-二縮水甘油基 二縮水甘油基-胺基甲基環己烷、3-(N-烯丙基-N 基)胺基丙基三甲氧基矽烷、3-(N,N-二縮水甘油 基三甲氧基矽烷等。 如上所述的接著性提升劑的使用比率,對於 r I 配向劑,相對於100重量份上述式(1)表示的化合 爲40重量份以下,更佳爲0.1〜30重量份。另夕j 二液晶配向劑,相對於1 00重量份由上述通式(1 化合物與四羧酸二酐反應所得的聚醯胺酸,較佳 份以下,更佳爲0.1〜2 5重量份。 本發明的液晶配向劑通過將上述式(1)表示 或者由上述式(1’ )表示的化合物與四羧酸二酐 的聚醯胺酸以及任意添加的其他成分較佳爲溶於 基-3-胺基 三甲氧基 等。 環氧化合 醇二縮水 甘油醚、 、1,6-己二 戊二醇二 3二醇、 (N,N-二縮 水甘油基 F 胺、N,N --縮水甘油 基)胺基丙 ‘第一液晶 「物,較佳 、’對於第 ’)表示的 爲3 0重量 的化合物 :反應所得 卜有機溶劑 -38- 200832019 中而調製。調製本發明液晶配向劑時的溫度較佳爲〇 °c〜 200°C,更佳爲 20°C 〜60°C。 作爲可用於本發明液晶配向劑的有機溶劑,可以舉出 例如1-甲基-2-吡咯烷酮、r -丁內酯、r -丁內醯胺、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、4-羥基-4 -甲基-2-戊 酮、乙二醇單甲基醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸 甲酯、乙氧基丙酸乙酯、乙二醇甲基醚、乙二醇乙基醚、 乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚(丁基 f.' k 溶纖劑)、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、二甘醇 二甲基醚、二甘醇二乙基醚、二甘醇單甲基醚、二甘醇單 乙基醚、二甘醇單甲基醚乙酸酯、二甘醇單乙基醚乙酸酯、 丙酸異戊酯、異丁酸異戊酯、二異戊基醚、3-丁氧基-N,N-二甲基丙醯胺、3-甲氧基-N,N-二甲基丙醯胺、3-己基氧基 -Ν,Ν-二甲基丙醯胺等。其中,3-丁氧基-Ν,Ν-二甲基丙醯 胺、3-甲氧基-Ν,Ν-二甲基丙醯胺、3-己基氧基- Ν,Ν-二甲基 丙醯胺由於顯示良好的印刷性而特佳。 & 本發明液晶配向劑中固體成分濃度(從液晶配向劑的 全部成分除去溶劑後的重量再除以液晶配向劑的總重量的 値)係考慮黏性、揮發性等而進行選擇,較佳爲1〜1 0重量 %的範圍。換句話說,將本發明液晶配向劑塗敷於基板表 面,形成作爲液晶配向膜的塗膜,當固體成分濃度不足1 重量%時,將導致該塗膜的膜厚過小,從而不能得到良好的 液晶配向膜;又,當固體成分濃度超過1 0重量%時,將導 致塗膜膜厚過厚,從而不能得到良好的液晶配向膜,並且, -39- 200832019 會出現液晶配向劑的黏性增大,塗敷特性變差的情況。 另外,特佳的固體成分濃度的範圍,因將液晶配向劑 塗敷於基板時所使用的方法而不同。例如,使用旋塗法的 場合,特佳爲1 · 5〜4 · 5重量%的範圍。使用印刷法的場合, 固體成分濃度爲3〜9重量%的範圍,由此,特佳的溶液黏 度爲12〜50mPai的範圍。使用噴墨法的場合,固體成分 濃度爲1〜5重量%的範圍,由此,特佳的溶液黏度爲3〜 1 5 m P a · s的範圍。 f' _ % 本發明的液晶顯示元件具有由本發明液晶配向劑形成 的液晶配向膜。 本發明的液晶顯示元件,可以通過例如以下的方法製 造。 (1)通過平版印刷法、旋塗法或者噴墨印刷法,將本發明 的液晶配向劑塗敷在設有形成圖案的透明導電膜的基板的 一面上,接著,通過加熱塗敷面形成塗膜。這裏,作爲基 板,可以使用例如浮法玻璃、鈉鈣玻璃等玻璃;由聚對苯 % 二甲酸乙二醇酯、聚對苯二甲酸丁二醇酯、聚醚颯、聚碳 酸酯、脂環式聚烯烴等塑膠所構成透明基板。作爲基板的 一面上所設置的透明導電膜,可以使用由氧化錫(S η Ο 2)所 構成的NES Α膜(美國PPG公司註冊商標)、由氧化銦一氧 化錫(In2〇3 — SnOO所構成的ITO膜等,這些透明導電膜的 形成圖案使用光蝕刻法或預先使用遮罩的方法。在液晶配 向劑的塗敷時,爲了進一步改善基板表面和透明導電膜與 塗膜的接著性,還可以在基板的該表面上預先塗敷含官能性 -40- 200832019 矽烷化合物、含官能性鈦化合物等。塗敷液晶配向劑後, 爲了防止塗敷的配向劑的液體下垂等,較佳爲實施預加熱 (預烘焙(pre-bake))。預烘焙的溫度較佳爲30〜200 °C,更 佳爲40〜150°C,特佳爲40〜100°C。然後,將溶劑完全除 去,以將聚醯胺酸熱醯亞胺化爲目的,實施焙燒(後烘焙 (post-bake))製程。該焙燒(後烘焙)溫度爲80〜3 00 °C,較 佳爲1 2 0〜2 5 (TC。另外,含聚醯胺酸的本發明液晶配向劑, 通過塗敷後除去有機溶劑,形成作爲配向膜的塗膜,還可 < 以通過進一步加熱使其進行脫水閉環,形成進一步醯亞胺 化的塗膜。形成的塗膜的膜厚較佳爲0.0 0 1〜1 μηι,更佳爲 0.005 〜0·5μιη 〇 (2) 對所形成的塗膜面用纏有例如由尼龍、人造纖維、棉 花等纖維所構成的布的輥進行以一定方向摩擦的打磨處 理。這樣,製成在塗膜上產生了液晶分子配向能的液晶配 向膜。另外,對由本發明液晶配向劑形成的液晶配向膜, 進行如例如專利文獻2(日本特開平6 - 222 3 6 6號公報)或專 利文獻3 (日本特開平6 — 2 8 1 9 3 7號公報)中所示般,藉由部 分照射紫外線而使預傾角改變的處理,或者進行如專利文 獻4(日本特開平5 — 1 07544號公報)中所示般,在已實施打 磨處理的液晶配向膜表面上部分地形成保護膜,以與先前 打磨處理不同的方向進行打磨處理後,除去保護膜,使液 晶配向膜的液晶配向能改變的處理,這樣能夠改善液晶顯 示元件的視野特性。 (3) 如上述般進行而製作 2片已形成液晶配向膜的基 -41 - 200832019 板,將2片基板隔著間隙(晶胞間隙)相對放置,使各自液 晶配向膜的打磨方向相互垂直或逆平行,將2片基板之周 邊部位用密封劑貼合,向由基板表面和密封劑所區隔出的 晶胞間隙內注入充塡液晶’封閉注入孔,構成液晶胞。然 後,在液晶胞的外表面,即構成液晶胞的各基板的另一側 面上,貼合偏光板,使其偏光方向與該基板的一面上所形 成的液晶配向膜的打磨方向一致或者垂直,製得液晶顯示 元件。這裏,作爲密封劑’可以使用例如作爲固化劑和間 隙物的含氧化鋁球的環氧樹脂等。作爲液晶,可以舉出向 列型液晶和碟狀型液晶’其中較佳爲向列型液晶’可以使 用例如希夫氏鹼類液晶、氧化偶氮基類液晶、聯苯類液晶、 苯基環己烷類液晶、酯類液晶、三聯苯類液晶、聯苯基環 己烷類液晶、嘧啶類液晶 '二氧陸圜類液晶 '雙環辛烷類 液晶、立方烷類液晶等。此外’這些液晶中還可以添加例 如氯化膽甾醇、膽甾醇壬酸酯、膽甾醇碳酸酯等膽甾型液 晶和以商品名“C-15” 、 “CB-15” (默克公司製)銷售的手 性劑等而進行使用。並且’還可以使用對-癸氧基苯亞甲基 -對-胺基-2 -甲基丁基肉桂酸酯等鐵電性液晶。另外’作爲 液晶胞外表面上貼合的偏光板’可以舉出將聚乙烯醇一邊 延伸配向一邊吸收碘所得的稱作爲Η膜的偏光膜夾在醋酸 纖維素保護膜中而製成的偏光板或者Η膜自身製成的偏光 板。 【實施例】 以下,通過實施例對本發明進行更具體的說明’但是本 -42- 200832019 發明並不局限於這些實施例。 在以下的實施例和比較例中,液晶配向劑和由其製得的 液晶配向膜的評價按照以下的方法Μ θ。 [電壓保持率] 在1 6 7毫秒的時間間隔內,在6 〇它下對液晶顯示元件施 加5V的電壓’電壓施加時間爲6〇微秒,然後測定從電壓 解除至1 6 7毫秒後的電壓保持率。測定裝置使用東陽科技 (股)製的VHR-1。 Γ' [殘影實驗] 製作如第1圖所示的帶有IΤ 0電極的晶胞。在室溫下, 向電極Α施加2 4小時1 0 · 0 V直流電壓,向電極Β施加2 4 小時0.5 V直流電壓。解除電壓後,向電極a、B以〇 . 1 v 的梯度施加〇 . 1〜5.0 V直流電壓,通過各電壓下電極a、B 的亮度差判斷殘影特性。當亮度差大時,殘影特性判斷爲 差。沒有發現殘影的記爲〇,發生殘影的記爲X。 f [印刷性評價] 預備在一側面的整面上形成了 I Τ Ο膜的1 2 7 m m (D ) X 1 2 7 m m (W) x 1 · 1 m m (Η)玻璃基板,將各實施例或各比較例中 製得的液晶配向劑用孔徑爲〇 . 2 μηι的微孔濾器過濾後,用 液晶配向膜塗敷用印刷機(日本照相印刷(股)製造, Angstromer S-40L)塗敷於該玻璃基板的透明電極面上。通 過設定爲80°C的加熱板緊貼式預乾燥機除去溶劑,在200 °C下焙燒60分鐘,從而在帶有ITO膜的玻璃基板上形成液 晶配向膜。對所得之配向膜的不勻進行目視評價,沒有發 -43- 200832019 現不勻的記作爲“〇”。 合成例1 合成例1按照非專利文獻2(K. Hasegawa,Polymer Journal. Vol. 31,No. 2,206(1999))進行。 在氣热環境下’將2,7-二漠荀3.24g(10mmol)和對苯二 胺2.16g(20mmol)加入到300mL的三頸燒瓶中,再向其中 加入80mL甲苯使其溶解。然後在室溫下向該溶液中加入3 級丁氧基鈉 5.8g(60mmol)、三(二亞苄基丙酮)-二鈀 r · ' (Pd2(dba)3)0.46g(0.5mmol)和 2,2’-二(二苯基膦)-1,1’-二萘 基(ΒΙΝΑΡ)0·9 3 g(l .5mmol),並使其溶解。將該溶液在氮氣 下於1 〇 〇 °C攪拌1 6小時使其反應。反應結束後,使反應混 合物降回到室溫,使用分液漏斗,用2升氨水與甲醇的混 合溶液(氨水/甲醇=1/4 (體積比))進行洗滌。將有機溶劑層 用硫酸鈉脫水後,用旋轉蒸發儀濃縮,將所得粗產物通過 氧化矽凝膠層析進行精製,得到2.2g下述式(A — 1)表示的 化合物(以下,稱爲“特定化合物A - 1 ” )。In the case of the poly-10% solution having the repeating amine acid represented by the above formula (I-1) or the repeating unit represented by the above formula (I-2), preferably having a composition of 20 to 800 mPa, Preferably, the polymer has a viscosity of 30 to 500 mPa.s. Further, the solution viscosity (mPa's) of the polymer is measured by using E Γ at 25 ° C for a solution diluted to a solid concentration of 10%. When the liquid crystal alignment agent of the present invention is a polyaminic acid having a repeating unit having the above formula or a polyimine having the above formula (I-2), the ratio of use thereof is 1 part by weight for the first liquid crystal. The compound represented by the above formula (1) is preferably the following, more preferably 10 to 500 parts by weight. Further, the poly-proline which is obtained by reacting the chemical &acid dianhydride represented by the above formula (1') with respect to 1 part by weight of the first agent is preferably 100 to 80 parts by weight. The liquid crystal alignment agent of the present invention preferably contains both polylysine having a repeating unit represented by 1) and polyamidiamine having a repeating unit of the above formula (). In this case, the above formula (poly unit of repeating unit) The total amount of the amine acid and the polyamidene represented by the above formula (I-2) is preferably a polyamine derivative having a repeating unit represented by the above formula (I-1) within the above range (I - 2) The use of the polyimine of the repeating unit represented by t. For example, a poly-imine of a different unit, a solvent of a polystyrene at a viscosity of s, a rotational viscosity of the type: (I-1) represents a repeat a single alignment agent, a phase of 100 parts by weight of a liquid crystal alignment compound and a tetracarboxylic component or less, and a repeating unit represented by the above formula (I-t-2), which is represented by 1 to 1). The total amount of the polyacetic acid having the repeating unit represented by the above formula (I-1) and the polyimine having the repeating unit represented by the above formula (I-2) with respect to -36 - 200832019 The polyamine amount of the repeating unit represented by the above formula (I-1) is preferably used in an amount of 5 0 to 95% by weight, more preferably 55 to 90% by weight. Polylysine having a repeating unit represented by the above formula (I-1) and polyimine having a repeating unit represented by the above formula (I-2) Preferably, each is a polymer synthesized from a tetracarboxylic dianhydride containing 2,3,5-tricarboxycyclopentylacetic acid dianhydride and a diamine. In this case, 2,3,5-tricarboxycyclopentane The amount of the acetic acid dianhydride to be used is preferably 50% by mole or more based on the total amount of the tetracarboxylic dianhydride. The above-mentioned adhesion improving agent may, for example, be a compound containing a functional decane or a formula (1) or a formula. An epoxy compound other than the compound represented by (1'). The functional decane-containing compound may, for example, be 3-aminopropyltrimethoxydecane or 3-aminopropyltriethoxydecane, 2 -Aminopropyldimethoxylate, 2-aminopropyltriethoxylate, Ν-(2.Aminoethyl)_3-aminopropyltrimethoxydecane, Ν-(2 -aminoethyl)-3-aminopropylmethyldimethoxydecane, 3-ureidopropyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl- 3- Propyltrimethoxydecane, N-ethoxycarbonyl-3-aminopropyltriethoxydecane, N-triethoxydecylpropyltriethylamine, N-trimethoxydecyl Propyltriethylamine, 10-trimethoxydecyl-1,4,7-triazadecane, 1 〇-triethoxydecyl-1,4,7-triazaindene Alkane, 9-trimethoxydecyl-3,6-diazaindolyl acetate, 9-triethoxydecyl-3,6-diazaindolyl acetate, N-benzyl- 3-Aminopropyltrimethoxydecane, N-benzyl-3-aminopropyltriethoxy-37-200832019 decane, N-phenyl-3-aminopropyltrimethoxydecane, N- Phenylpropyltriethoxydecane, N-bis(oxyvinyl)-3-aminopropyldecane, N-bis(oxyvinyl)-3-aminopropyltriethoxydecane as formula (1) And a compound other than the compound represented by the formula (1 '), for example, ethylene glycol diglycidyl ether, polyethylene diglyceryl ether, propylene glycol diglycidyl ether, tripropylene glycol dihydrate polypropylene glycol diglycidyl ether, new Pentyl glycol diglycidyl ether alcohol diglycidyl ether, glycerol diglycidyl , 2,2-dibromo neoglycidyl ether, 1,3,5,6-tetraglycidyl-2,4-EN,N,N',N'-tetraglycidyl-xylylenediamine, 1,3-Diglycerylaminomethyl)cyclohexane, N,N,N',N'-tetra--4,4'-diaminodiphenylmethane, N,N-diglycidyl Glycidyl-aminomethylcyclohexane, 3-(N-allyl-N-yl)aminopropyltrimethoxydecane, 3-(N,N-diglycidyltrimethoxydecane Wait. The use ratio of the adhesion promoter as described above is 40 parts by weight or less, more preferably 0.1 to 30 parts by weight, per 100 parts by weight of the compound represented by the above formula (1). Further, the liquid crystal alignment agent is preferably used in an amount of from 0.1 to 25 parts by weight, based on 100 parts by weight of the polyamic acid obtained by reacting the compound of the above formula (1 with tetracarboxylic dianhydride). The liquid crystal alignment agent of the present invention is preferably dissolved in the base-3 by the compound represented by the above formula (1) or the compound represented by the above formula (1') and the polyamic acid of the tetracarboxylic dianhydride and optionally added other components. -Aminotrimethoxy, etc. Epoxylated alcohol diglycidyl ether, 1,6-hexane dipentanediol di 3 glycol, (N,N-diglycidyl F amine, N,N - shrinkage The glyceryl)aminopropyl 'first liquid crystal substance, preferably, 'for the ''), is a compound of 30 weight: the resulting organic solvent -38-200832019 is prepared. When preparing the liquid crystal alignment agent of the present invention The temperature is preferably 〇 ° c to 200 ° C, more preferably 20 ° C to 60 ° C. As the organic solvent which can be used in the liquid crystal alignment agent of the present invention, for example, 1-methyl-2-pyrrolidone, r -butyrolactone, r-butyrolactam, N,N-dimethylformamide, N,N-dimethylacetamide, 4-hydroxy-4 Ketopentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol Ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether (butyl f.' k cellosolve), ethylene glycol dimethyl ether, ethylene glycol ethyl ether Acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol Monoethyl ether acetate, isoamyl propionate, isoamyl isobutyrate, diisoamyl ether, 3-butoxy-N,N-dimethylpropanamide, 3-methoxy- N,N-dimethylpropanamide, 3-hexyloxy-oxime, hydrazine-dimethylpropionamide, etc. Among them, 3-butoxy-indole, hydrazine-dimethylpropanamide, 3- Methoxy-oxime, Ν-dimethylpropanamide, 3-hexyloxy-oxime, Ν-dimethylpropanamide are particularly excellent in exhibiting good printability. & Solid in liquid crystal alignment agent of the present invention Component concentration (the weight after removing the solvent from all the components of the liquid crystal alignment agent and dividing by the total weight of the liquid crystal alignment agent) The viscosity is selected in consideration of viscosity, volatility, etc., preferably in the range of 1 to 10% by weight. In other words, the liquid crystal alignment agent of the present invention is applied to the surface of the substrate to form a coating film as a liquid crystal alignment film, when solid When the concentration of the component is less than 1% by weight, the film thickness of the coating film is too small to obtain a good liquid crystal alignment film; and when the solid content concentration exceeds 10% by weight, the film thickness of the coating film is too thick, thereby A good liquid crystal alignment film cannot be obtained, and -39-200832019 may cause an increase in viscosity of the liquid crystal alignment agent, and the coating characteristics may be deteriorated. In addition, a particularly preferable range of solid content concentration is due to application of a liquid crystal alignment agent. The method used when applying the substrate differs. For example, in the case of using the spin coating method, it is particularly preferably in the range of 1 · 5 to 4 · 5 % by weight. When the printing method is used, the solid content concentration is in the range of 3 to 9 % by weight, whereby a particularly preferable solution viscosity is in the range of 12 to 50 mPai. When the ink jet method is used, the solid content concentration is in the range of 1 to 5 % by weight, whereby a particularly preferable solution viscosity is in the range of 3 to 15 m P a · s. F' _ % The liquid crystal display element of the present invention has a liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention. The liquid crystal display element of the present invention can be produced, for example, by the following method. (1) The liquid crystal alignment agent of the present invention is applied onto one surface of a substrate provided with a patterned transparent conductive film by a lithography method, a spin coating method or an inkjet printing method, and then coated by heating the coated surface. membrane. Here, as the substrate, for example, glass such as float glass or soda lime glass; polyethylene terephthalate, polybutylene terephthalate, polyether oxime, polycarbonate, and alicyclic ring can be used. A transparent substrate made of a plastic such as a polyolefin. As the transparent conductive film provided on one surface of the substrate, a NES film (registered trademark of PPG, USA) composed of tin oxide (S η Ο 2) and indium tin oxide (In2〇3 - SnOO) can be used. In the ITO film or the like, the pattern of forming the transparent conductive film is a photolithography method or a method in which a mask is used in advance. In order to further improve the adhesion between the substrate surface and the transparent conductive film and the coating film during the application of the liquid crystal alignment agent, Further, a functionalized-40-200832019 decane compound, a functional titanium-containing compound, or the like may be applied to the surface of the substrate. After the liquid crystal alignment agent is applied, it is preferably used to prevent liquid sag of the applied alignment agent. Pre-heating (pre-bake) is carried out. The pre-baking temperature is preferably from 30 to 200 ° C, more preferably from 40 to 150 ° C, particularly preferably from 40 to 100 ° C. Then, the solvent is completely removed. The calcination (post-bake) process is carried out for the purpose of the imidization of the polyglycolic acid. The calcination (post-baking) temperature is 80 to 300 ° C, preferably 1 2 0 2 5 (TC. In addition, the liquid crystal of the invention containing poly-proline The alignment agent is formed by removing the organic solvent to form a coating film as an alignment film, and may further perform dehydration ring closure by further heating to form a coating film which is further imidized. The film thickness of the formed coating film is formed. It is preferably 0.00 1 to 1 μηι, more preferably 0.005 to 0·5 μιη 〇 (2) The formed coating film surface is coated with a roll wrapped with a cloth composed of fibers such as nylon, rayon, cotton or the like. In the same manner, a liquid crystal alignment film in which the alignment property of the liquid crystal molecules is generated on the coating film is produced. Further, the liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention is subjected to, for example, Patent Document 2 (Japanese Patent Laid-Open No.) The process of changing the pretilt angle by partially irradiating ultraviolet rays, or performing the patent, as shown in the Japanese Patent Laid-Open No. Hei 6-281-93 In the case of the liquid crystal alignment film which has been subjected to the rubbing treatment, a protective film is partially formed as shown in the document 4 (Japanese Laid-Open Patent Publication No. Hei No. Hei. No. Hei. After that, the protective film is removed, and the liquid crystal alignment of the liquid crystal alignment film can be changed, so that the field of view characteristics of the liquid crystal display element can be improved. (3) Two substrates having formed a liquid crystal alignment film are formed as described above -41 - 200832019 The two substrates are placed opposite each other with a gap (cell gap) so that the polishing directions of the respective liquid crystal alignment films are perpendicular or anti-parallel to each other, and the peripheral portions of the two substrates are bonded together with a sealant to the surface of the substrate and sealed. a liquid crystal cell is enclosed in the cell gap separated by the agent to form a liquid crystal cell. Then, the polarizing plate is attached to the outer surface of the liquid crystal cell, that is, the other side surface of each substrate constituting the liquid crystal cell. The liquid crystal display element was obtained by making its polarization direction coincide with or perpendicular to the rubbing direction of the liquid crystal alignment film formed on one side of the substrate. Here, as the sealant', for example, an alumina ball-containing epoxy resin as a curing agent and a gap can be used. Examples of the liquid crystal include a nematic liquid crystal and a dish-shaped liquid crystal. Among them, a nematic liquid crystal is preferable. For example, a Schiff base liquid crystal, an oxidized azo liquid crystal, a biphenyl liquid crystal, or a phenyl ring can be used. A hexane liquid crystal, an ester liquid crystal, a terphenyl liquid crystal, a biphenylcyclohexane liquid crystal, a pyrimidine liquid crystal 'dioxanthene liquid crystal' bicyclooctane liquid crystal, a cuba liquid crystal, or the like. Further, in these liquid crystals, cholesteric liquid crystals such as cholesteryl cholesteryl, cholesteryl phthalate, and cholesteryl carbonate may be added, and under the trade names "C-15" and "CB-15" (manufactured by Merck) It is used by selling chiral agents and the like. Further, a ferroelectric liquid crystal such as p-nonyloxybenzylidene-p-amino-2-methylbutylcinnamate may also be used. In addition, a polarizing plate which is formed by sandwiching a polarizing film called a ruthenium film which is obtained by absorbing iodine while extending polyvinyl alcohol from the outer surface of the liquid crystal, is exemplified by a polarizing plate. Or a polarizing plate made of the diaphragm itself. [Examples] Hereinafter, the present invention will be more specifically described by way of examples. However, the invention is not limited to the examples. In the following examples and comparative examples, the evaluation of the liquid crystal alignment agent and the liquid crystal alignment film produced therefrom was carried out according to the following method Μ θ. [Voltage Retention Rate] A voltage of 5 V was applied to the liquid crystal display element at 6 〇 in a time interval of 167 ms. The voltage application time was 6 〇 microseconds, and then the voltage was released from the voltage release to 167 ms. Voltage retention rate. The measuring device used VHR-1 manufactured by Dongyang Technology Co., Ltd. Γ' [After image experiment] A cell with an IΤ 0 electrode as shown in Fig. 1 was produced. At room temperature, a DC voltage of 1 0 · 0 V was applied to the electrode crucible for 24 hours, and a DC voltage of 0.5 V was applied to the electrode crucible for 24 hours. After the voltage was released, 电极1 to 5.0 V DC voltage was applied to the electrodes a and B in a gradient of 11 v, and the residual image characteristics were judged by the difference in luminance between the electrodes a and B at the respective voltages. When the luminance difference is large, the afterimage characteristic is judged to be poor. No remnants were found as 〇, and afterimages were recorded as X. f [Printability evaluation] A 1 2 7 mm (D ) X 1 2 7 mm (W) x 1 · 1 mm (Η) glass substrate with an I Τ film formed on the entire surface of one side is prepared. The liquid crystal alignment agent prepared in the examples or the respective comparative examples was filtered with a microporous filter having a pore diameter of μ. 2 μηι, and then coated with a liquid crystal alignment film coating printing machine (manufactured by Japan Photographic Co., Ltd., Angstromer S-40L). Apply to the transparent electrode surface of the glass substrate. The solvent was removed by a hot plate-fitting pre-dryer set at 80 ° C, and baked at 200 ° C for 60 minutes to form a liquid crystal alignment film on a glass substrate with an ITO film. The unevenness of the obtained alignment film was visually evaluated, and no unevenness was reported as "〇". Synthesis Example 1 Synthesis Example 1 was carried out in accordance with Non-Patent Document 2 (K. Hasegawa, Polymer Journal. Vol. 31, No. 2, 206 (1999)). 2,7-dimethane 3.24 g (10 mmol) and p-phenylenediamine 2.16 g (20 mmol) were placed in a 300 mL three-necked flask under an aerobic environment, and then 80 mL of toluene was added thereto to dissolve. Then, to the solution, 5.8 g (60 mmol) of sodium butoxide, 0.36 g (0.5 mmol) of tris(dibenzylideneacetone)-dipalladium r · '(Pd2(dba)3) and 2,2'-bis(diphenylphosphino)-1,1'-dinaphthyl (fluorene) 0·9 3 g (1.5 mmol) was dissolved. The solution was stirred under nitrogen at 1 〇 ° C for 16 hours to cause a reaction. After completion of the reaction, the reaction mixture was returned to room temperature, and washed with a mixture of 2 liters of aqueous ammonia and methanol (ammonia/methanol = 1/4 (volume ratio)) using a separating funnel. The organic solvent layer was dehydrated with sodium sulfate, and concentrated by a rotary evaporator. The obtained crude product was purified by yttrium gel chromatography to obtain 2.2 g of the compound represented by the following formula (A-1) (hereinafter referred to as " Specific compound A - 1 ").

合成例2 除了在合成例1中使用3.97g(20mmol)4,4’-二胺基二苯 基甲烷代替2 · 1 6 g ( 2 0 m m ο 1)對苯二胺以外,與合成例1同樣 地操作,得到2.4g下述式(A - 2)表示的化合物(以下,稱爲 -44- 200832019 “特定化合物A — 2 ”)。Synthesis Example 2 A synthesis example 1 was used except that 3.97 g (20 mmol) of 4,4'-diaminodiphenylmethane was used instead of 2 · 16 g (20 mm ο 1) of p-phenylenediamine in Synthesis Example 1. In the same manner, 2.4 g of a compound represented by the following formula (A-2) (hereinafter referred to as -44-200832019 "specific compound A-2") was obtained.

合成例3Synthesis Example 3

除了在合成例1中使用3.12g(10mmol)4,4’-二溴聯苯代 替 3.24g(10mmol)2,7-二溴芴,並使用 3.97g(20mmol)4,4,-二胺基二苯基甲烷代替2.16g(20mmol)對苯二胺以外,與合 成例1同樣地操作,得到4 · 2 g下述式(A — 3 )表示的化合物 (以下,稱爲“特定化合物A - 3 ”)。Except that in Synthesis Example 1, 3.12 g (10 mmol) of 4,4'-dibromobiphenyl was used instead of 3.24 g (10 mmol) of 2,7-dibromofluorene, and 3.97 g (20 mmol) of 4,4,-diamino group was used. In the same manner as in Synthesis Example 1, except that diphenylmethane was replaced by 2.16 g (20 mmol) of p-phenylenediamine, 4 2 g of a compound represented by the following formula (A-3) was obtained (hereinafter, referred to as "specific compound A - 3").

合成例4 將 0.63g(1.66mmol)特定化合物 A — 1 和 1.23g(13.3mmol) 環氧氯丙烷溶於1 OmL THF和1 .5mL水的混合溶劑中,在 80 °C下攪拌4小時。然後使溫度降低到60 °C,滴加lg 50%Synthesis Example 4 0.63 g (1.66 mmol) of the specific compound A-1 and 1.23 g (13.3 mmol) of epichlorohydrin were dissolved in a mixed solvent of 10 mL of THF and 1.5 mL of water, and stirred at 80 ° C for 4 hours. Then reduce the temperature to 60 °C, add lg 50%

的NaOH水溶液。繼續在60 °C下攪拌4小時後,減壓蒸飽 除去未反應的環氧氯丙烷。將殘留物在甲苯/水中進行分液 洗滌,然後蒸餾除去溶劑,得到〇.75g下述式(Β_ υ表示Aqueous NaOH solution. After stirring at 60 ° C for 4 hours, the unreacted epichlorohydrin was removed by evaporation under reduced pressure. The residue was subjected to liquid separation washing in toluene/water, and then the solvent was distilled off to obtain 〇.75 g of the following formula (Β υ υ

合成例5 (使用特定化合物Α - 1的聚醯胺酸的合成i) 將196 g( 1.0莫耳)作爲四羧酸二酐的1,2,3,4-環丁院四羧 酸二酐和3 24 g( 1.0莫耳)作爲二胺化合物,通過與合成例1 -45- 200832019 同樣的方法所合成的特定化合物A〜1溶解於4 7 0 g N -甲基 -2 -吡咯院酮、4 2 0 0 g r - 丁內酯中,使其在4 0 °C下反應3小 時,得到約5 0 0 0 g在固體成分濃度1 〇 %下的溶液黏度爲 l6 0mPa.s的聚醯胺酸(以下,稱爲“特定化合物C — 1”)溶 液。 合成例6(使用特定化合物A— 1的聚醯胺酸的合成2) 將98g(0.5莫耳)作爲四羧酸二酐的ι,2,3,4-環丁烷四羧 酸二酐和109g(0.5莫耳)均苯四酸,和324g(l.〇莫耳)作爲 C 二胺化合物,通過與合成例1同樣的方法所合成的特定化 合物A — 1溶解於3 0 0 g N -甲基-2 -吡咯烷酮、2 7 0 0 g r - 丁內 酯中,使其在4 0 °C下反應3小時,然後追加1 7 7 0 g r - 丁內 酯,得到約5100g在固體成分濃度10%下的溶液黏度爲 125mPa,s的聚醯胺酸(以下,稱爲“特定化合物c — 2”)溶 液。 合成例7 (使用特定化合物a - 3的聚醯胺酸的合成1) 將196g(1.0莫耳)作爲四羧酸二酐的ι,2,3,4-環丁烷四羧 t 酸二酐和5478(1.0莫耳)作爲二胺化合物,通過與合成例3 同樣的方法所合成的特定化合物A - 3溶解於6 7 0 g N -甲基 -2-吡咯烷酮、6000g γ -丁內酯中,使其在4(Γ(:下反應3小 時,得到約7000g在固體成分濃度10%下的溶液黏度爲 140mPa.s的聚醯胺酸(以下,稱爲“特定化合物c — 3”)溶 液。 合成例8(使用特定化合物a一 3的聚醯胺酸的合成2) 將98 g(0.5莫耳)作爲四羧酸二酐的me環丁烷四羧 -46- 200832019 酸二酐和1 0 9 g ( 0 · 5莫耳)均苯四酸,和5 4 7 g ( 1 · 0莫耳)作爲 二胺化合物,通過與合成例3同樣的方法所合成的特定化 合物Α — 3溶解於430g Ν -甲基-2-吡咯烷酮、3850gr -丁內 酯中,使其在4 0 °C下反應3小時,然後追加2 5 0 0 g r - 丁內 酯,得到約72 OOg在固體成分濃度10%下的溶液黏度爲 12 8mPa.s的聚醯胺酸(以下,稱爲“特定化合物C — 4”)溶 液。 聚醯亞胺合成例1 將作爲四羧酸二酐的2,3 , 5 -三羧基環戊基醋酸二酐 112g(0.50 莫耳)和 l,3,3a,4,5,9b-六氫·8-甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]呋喃-l,3-二酮 157g(0.50 莫 耳),作爲二胺化合物的對-苯二胺96g(0.89莫耳)、3,3’-(四 甲基二矽氧烷-1,3-二基)二(丙胺)25g(0.10莫耳)和3,6-二 (4-胺基苯甲醯氧基)膽甾烷13g(0.02 0莫耳)、作爲單胺的 正十八烷基胺8.1g(0.03 0莫耳)溶於960g N-甲基-2-吡咯烷 酮中,使其在60 °C下反應6小時。將得到的聚醯胺酸溶液 分取少量,加入NMP,在固體成分濃度10%的溶液下測定 黏度,溶液黏度爲6 0 m P a · s。在所得聚醯胺酸溶液中追加 2 7 0 0 g N -甲基-2 -吡咯烷酮,添加3 9 6 g吡啶和4 0 9 g醋酸酐, 在1 1 〇 °C下脫水閉環4小時。醯亞胺化反應後,將體系內 的溶劑以新的7 - 丁內酯進行溶劑置換(在本操作中,將醯 亞胺化反應中使用的吡啶、醋酸酐除去至體系外),得到約 2〇〇〇g固體成分濃度15wt%、固體成分濃度1〇%時(7 -丁內 酯溶液)的溶液黏度爲7〇111?&1、醯亞胺化率約95%的醯亞 -47- 200832019 胺化聚合物(其作爲“聚醯亞胺(a-l)”)溶液。 聚醯亞胺合成例2 將作爲四羧酸二酐的2,3,5 -三羧基環戊基醋酸二酉干 224g(1.0莫耳),作爲二胺化合物的對-苯二胺l〇8g(l.〇莫 耳)和3,5-二胺基苯甲酸膽甾烷基酯7.8g(0.015莫耳)溶於 3 0 3 9 g N -甲基-2 -吡咯烷酮中,使其在6 0 °C下反應6小時, 得到溶液黏度約爲260mPa.s的聚醯胺酸溶液。接著,在所 得聚醯胺酸溶液中追加2700g N-甲基-2-吡咯烷酮,添加 ^ 3 9 6 g吡啶和3 0 6 g醋酸酐,在1 1 0 °C下脫水閉環4小時。醯 亞胺化反應後,將體系內的溶劑以新的r -丁內酯進行溶劑 置換(在本操作中,將醯亞胺化反應中使用的吡啶、醋酸酐 除去至體系外)’得到約3 000g固體成分濃度約9.0wt%、固 體成分濃度10%時(r-丁內酯溶液)的溶液黏度爲25 0mPa· s、醯亞胺化率約5 1 %的醯亞胺化聚合物(其作爲“醯亞胺 化聚合物(a-2)”)溶液。 聚醯胺酸合成例1 ^ 將作爲四羧酸二酐的1,2,3,4·環丁烷四羧酸二酐 196g(1.0莫耳),作爲二胺化合物的2,2’-二甲基-4,4,-二胺 基聯苯212g(l.〇莫耳)溶於370g N -甲基-2-卩比略院酮,3300g r - 丁內酯中,使其在4 0 °C下反應3小時,得到約3 7 0 0 g 在固體成分濃度1 〇%下的溶液黏度爲1 60mPa.s的聚醯胺酸 (其作爲“聚醯胺酸(b - 1)”)溶液。 聚醯胺酸合成例2 將作爲四羧酸二酐的 1,2,3,4 -環丁烷四羧酸二酐 -48- 200832019 95g(0.50莫耳)、均苯四酸一酐l〇9g(〇.5〇莫耳),作爲二胺 化合物的2,7-二胺基荀196g(1.0莫耳)溶於23〇gN -甲基- 2-口比咯院酮,2 0 6 0 g τ - 丁內酯中’使其在4 〇。〇下反應3小時, 接著,追加1350g2 r -丁內酯’得到約3600g在固體成分 濃度1 0 %下的溶液黏度爲1 2 5 m P a · s的聚醯胺酸(其作爲 “聚醯胺酸(b — 2)”)溶液。 實施例1 將聚醯亞胺合成例1中製得的聚醯亞胺(a - 1 )和聚醯胺 酸合成例1中製得的聚醯胺酸(b - 1 )以聚醯亞胺:聚醯胺酸 =2 0 : 8 0 (重量比)溶於γ - 丁內酯/N -甲基-2 -吡咯烷酮/ 丁基溶 纖劑混合溶劑(重量比7 1 /1 7 /1 2 )中,相對於聚醯亞胺和聚 醯胺酸合計1 0 〇重量份’加入2重量份Ν,Ν,Ν,,Ν ’ -四縮水 甘油基-4,4’-二胺基二苯基甲烷,再相對於聚醯亞胺和聚醯 胺酸合計1 〇 0重量份,加入1 0重量份特定化合物Α - 1, 製成固體成分濃度爲3 · 5重量%的溶液和 6.0重量%的溶 液。將各溶液充分攪拌後,用孔徑爲1 μιη的濾器過濾,調 製出本發明的液晶配向劑。 使用旋塗機將上述液晶配向劑中固體成分濃度爲3 . 5 % 的溶液塗敷於厚度爲1 mm的玻璃基板的一面上所設置的由 ITO膜所構成的透明導電膜上(轉速:25 00rpm,塗敷時間: 1分鐘),在200°C下加熱1小時除去溶劑,形成膜厚爲 0.0 8 μ m的塗膜。使用裝有纒繞人造纖維製之布的輥的打磨 機’在輥轉速爲400 rpm、操作臺移動速度爲3cm/秒,絨毛 押入長度爲0 · 4mm的條件下,對該塗膜進行打磨處理。將 -49- 200832019 上述液晶配向膜塗敷基板在超純 後,在1 〇 〇 °c的乾淨烤箱中乾燥 明電極/透明電極基板的上述液 液晶配向膜的各外緣上,除液晶 直徑爲5 · 5 μ m的氧化銘球的環氧 晶配向膜面相對地重合並壓合, 過液晶注入口向基板間塡充向歹 MLC-6 22 1 ),然後用丙烯酸類光 封閉,製成液晶顯示元件。按照 得液晶顯示元件的電壓保持率評 另外,使用固體成分濃度爲 上所述的方法進行印刷性評價。 實施例2〜1 6 除了特定化合物、聚醯亞胺和 載的化合物以外,按照與實施例 用特定化合物C-l、C一 2、C一 亞胺和聚醯胺酸的合計1 0 0重量 定化合物。 實施例1 7 將聚醯亞胺合成例2中製得序 基-2-吡咯烷酮/丁基溶纖劑混合 對於1 00重量份聚醯亞胺加入7 甘油基-4,4,-二胺基二苯基甲烷 亞胺加入1 0重量份特定化合物 水中以超音波洗淨1分鐘 10分鐘。然後’在一對透 晶配向膜塗敷基板的具有 注入口以外’塗敷加入了 ,樹脂接著劑’然後’使液 使接著劑固化。接著,通 ‘[J型液晶(默克公司生產’ 固化黏合劑將液晶注入口 以上所述的方法進行對所 價和殘影評價。 6.0重量%的溶液,按照以 ]聚醯胺酸使用表1中所記 1同樣的流程進行。當使 3或C 一 4時,相對於聚醯 份,使用2 0重量份這些特 3聚醯亞胺(a— 2)溶於N-甲 溶劑(重量比5 0/ 5 0)中,相 ί重量份N,N,N’,N’-四縮水 ,再相對於100重量份聚醯 A - 1,製成固體成分濃度 -50- 200832019 爲3 . 5重量°/。的溶液和6 · 0重量%的溶液。將各溶液充分攪 拌後,用孔徑爲1 μηι的濾器過濾,調製出本發明的液晶配 向劑。液晶顯示元件的製作方法、液晶顯示元件的評價方 法以及配向劑印刷性的評價方法按照與實施例1相同的方 法進行。 實施例1 8〜2 4 除了使用表1中所記載的物質代替實施例1 7中的特$ _ 化合物人-1以外,按照與實施例17同樣的流程進行°另 外,當使用特定化合物C-l、C一 2、C一 3或C一 4時’相 對於100重量份聚醯亞胺,使用20重量份這些特定化合牧1 ° 比較例1、2 除了聚醯亞胺和聚醯胺酸使用表1中所記載的物胃’ # 且不添加特定化合物以外,按照與實施例1同樣的流^ 31 行。 比較例3 除了不添加特定化合物以外,按照與實施例1 7 Ν # w 流程進行。 上述實施例和比較例的結果全部一倂列於表1 °另# ’ 表1中,“一,,表示沒有使用該欄中的該成分。另外’ ® 壓保持率攔中的“>99%”表示測定値超過99%。 -51 - 200832019 表1 特定化合物 聚醯亞胺 聚醯胺酸 電壓保持率 殘影 印刷性 實施例1 A— 1 a—1 b — 1 >99% 〇 〇 實施例2 A-2 a—1 b-1 >99% 〇 〇 實施例3 A-3 a—1 b-1 >99% 〇 〇 實施例4 B-1 a—1 b—1 >99% 〇 〇 實施例5 C-1 a—1 b-1 >99% 〇 〇 實施例6 C一 2 a—1 b-1 >99% 〇 〇 實施例7 C一 3 a—1 b-1 >99% 〇 〇 實施例8 C-4 a—1 b-1 >99% 〇 〇 實施例9 A-1 a— 1 b-2 >99% 〇 〇 實施例10 A-2 a—1 b-2 >99% 〇 〇 實施例11 A—3 a—1 b-2 >99% 〇 〇 實施例12 B — 1 a—1 b-2 >99% 〇 〇 實施例13 C-1 a—1 b-2 >99% 〇 〇 實施例14 C-2 a-1 b-2 >99% 〇 〇 實施例15 C一 3 a—1 b-2 >99% 〇 〇 實施例16 C-4 a—1 b-2 >99% 〇 〇 實施例17 A-1 a-2 — >99% 〇 〇 實施例18 A-2 a—2 — >99% 〇 〇 實施例19 A—3 a—2 — >99% 〇 〇 實施例20 B — 1 a-2 — >99% 〇 〇 實施例21 C —1 a—2 — >99% 〇 〇 實施例22 C-2 a—2 — >99% 〇 〇 實施例23 C一3 a-2 — >99% 〇 〇 實施例24 C 一4 a—2 — >99% 〇 〇 比較例1 — a-1 b-1 >99% X 〇 比較例2 — a—1 b-2 >99% X 〇 比較例3 — a-2 — >99% X 〇 -52- 200832019 【圖式簡單說明】 第1圖爲實施例和比較例的殘影實驗而製作的晶胞的 示意圖。Synthesis Example 5 (Synthesis of polylysine using a specific compound Α-1) i 196 g (1.0 mol) of 1,2,3,4-cyclobutanine tetracarboxylic dianhydride as tetracarboxylic dianhydride And 3 24 g (1.0 mol) as a diamine compound, the specific compound A~1 synthesized by the same method as in Synthesis Example 1-45-200832019 was dissolved in 470 g N-methyl-2-pyrrolidone In 4 2 0 0 gr - butyrolactone, it was reacted at 40 ° C for 3 hours to obtain a polypyrene having a solution viscosity of 1600 mPa.s at a solid concentration of 1 〇%. A solution of an amine acid (hereinafter referred to as "specific compound C-1"). Synthesis Example 6 (Synthesis 2 of Polylysine Using Specific Compound A-1) 98 g (0.5 mol) of iota, 2,3,4-cyclobutanetetracarboxylic dianhydride of tetracarboxylic dianhydride and 109 g (0.5 mol) of pyromellitic acid, and 324 g (l. oxime) as a C diamine compound, the specific compound A-1 synthesized by the same method as in Synthesis Example 1 was dissolved in 300 g N - In methyl-2-pyrrolidone and 2700 gr-butyrolactone, the reaction was carried out at 40 ° C for 3 hours, and then 1 7 7 gr -butyrolactone was added to obtain about 5100 g at a solid concentration of 10 The solution viscosity at % is a solution of 125 mPa, s poly-proline (hereinafter referred to as "specific compound c-2"). Synthesis Example 7 (Synthesis 1 of polylysine using specific compound a-3) 196 g (1.0 mol) of iota, 2,3,4-cyclobutane tetracarboxylate dianhydride as tetracarboxylic dianhydride And 5478 (1.0 mol) as a diamine compound, the specific compound A-3 synthesized by the same method as in Synthesis Example 3 was dissolved in 670 g of N-methyl-2-pyrrolidone and 6000 g of γ-butyrolactone. So that it can be reacted at 4 (Γ for 3 hours to obtain a solution of about 7000 g of polyamic acid (hereinafter, referred to as "specific compound c-3") having a solution viscosity of 140 mPa·s at a solid concentration of 10%. Synthesis Example 8 (Synthesis 2 of Polylysine using a specific compound a-3) 98 g (0.5 mol) of me-cyclobutane tetracarboxylic acid-46-200832019 acid dianhydride and 1 as tetracarboxylic dianhydride 0 9 g (0 · 5 mol) pyromellitic acid, and 5 4 7 g (1·0 mol) as a diamine compound, the specific compound Α 3 synthesized by the same method as in Synthesis Example 3 was dissolved in 430 g of hydrazine-methyl-2-pyrrolidone and 3850gr-butyrolactone were reacted at 40 ° C for 3 hours, and then 2,500 gr - butyrolactone was added to obtain about 72 OOg of solid content. A solution having a solution viscosity of 10% at 12 8 mPa·s of poly-proline (hereinafter referred to as "specific compound C-4"). Polyimine synthesis Example 1 2, 3 as tetracarboxylic dianhydride 5-tricarboxycyclopentyl acetic acid dianhydride 112g (0.50 mol) and 1,3,3a,4,5,9b-hexahydro·8-methyl-5-(tetrahydro-2,5-dioxo -3-furanyl)-naphthalene [l,2-c]furan-1,3-dione 157 g (0.50 mol), p-phenylenediamine as a diamine compound 96 g (0.89 mol), 3,3 '-(Tetramethyldioxane-1,3-diyl)di(propylamine) 25g (0.10 mole) and 3,6-bis(4-aminobenzylideneoxy)cholane 13g ( 0.02 0 mol), 8.1 g (0.03 mmol) of n-octadecylamine as a monoamine was dissolved in 960 g of N-methyl-2-pyrrolidone, and allowed to react at 60 ° C for 6 hours. The poly-proline solution was divided into small amounts, NMP was added, and the viscosity was measured in a solution having a solid concentration of 10%. The viscosity of the solution was 60 m P a · s. 2 700 g was added to the obtained poly-proline solution. N-methyl-2-pyrrolidone, adding 3 9 6 g of pyridine and 4 0 9 g of acetic anhydride, dehydration and ring closure at 1 1 ° C for 4 hours. After that, the solvent in the system was replaced with a new 7-butyrolactone (in this operation, the pyridine and acetic anhydride used in the oxime imidization reaction were removed to the outside of the system) to obtain about 2 Å. g The solid concentration of 15% by weight, the solid concentration of 1% by weight (7-butyrolactone solution), the solution viscosity of 7〇111?1, and the oxime imidization rate of about 95% of the yttrium-47-200832019 amine A polymer (which acts as a "polyimine (al)") solution. Polyimine synthesis example 2 224 g (1.0 mol) of 2,3,5-tricarboxycyclopentylacetic acid dioxime as tetracarboxylic dianhydride, p-phenylenediamine 10 g as a diamine compound (l. 〇mol) and 3,5-diaminobenzoic acid cholesteryl 7.8 g (0.015 mol) dissolved in 3 0 3 9 g N-methyl-2-pyrrolidone, making it at 6 The reaction was carried out at 0 ° C for 6 hours to obtain a polyaminic acid solution having a solution viscosity of about 260 mPa·s. Next, 2700 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, and ^3 9 6 g of pyridine and 3,6 g of acetic anhydride were added, and the mixture was dehydrated and closed at 110 ° C for 4 hours. After the imidization reaction, the solvent in the system is replaced with a new r-butyrolactone (in this operation, the pyridine and acetic anhydride used in the oxime imidization reaction are removed to the outside of the system) 3 000g of yttrium imidized polymer having a solid concentration of about 9.0% by weight, a solid concentration of 10% (r-butyrolactone solution), a solution viscosity of 25 0 mPa·s, and a ruthenium iodide ratio of about 51% ( It is used as a solution of the "indoleized polymer (a-2)"). Polylysine Synthesis Example 1 196 g (1.0 mol) of 1,2,3,4·cyclobutanetetracarboxylic dianhydride as tetracarboxylic dianhydride as 2,2'-di of diamine compound Methyl-4,4,-diaminobiphenyl 212g (l. oxime) was dissolved in 370g of N-methyl-2-indole ketone, 3300g r - butyrolactone, making it at 40 The reaction was carried out at ° C for 3 hours to obtain about 370 g of polylysine having a solution viscosity of 1 60 mPa·s at a solid concentration of 1% by weight (as "polylysine (b-1)") Solution. Polylysine Synthesis Example 2 1,2,3,4-cyclobutanetetracarboxylic dianhydride as a tetracarboxylic dianhydride -48-200832019 95g (0.50 mole), pyromellitic acid anhydride 9g (〇.5〇莫耳), 2,7-diaminopurine as a diamine compound, 196g (1.0m) dissolved in 23〇gN-methyl-2-hydroxypyrrolidone, 2 0 6 0 g τ - butyrolactone in 'make it at 4 〇. The reaction was carried out for 3 hours, and then 1,350 g of 2 r -butyrolactone was added to obtain about 3,600 g of polylysine having a solution viscosity of 1 2 5 m P a · s at a solid concentration of 10% (as a "poly" Amino acid (b-2)") solution. Example 1 Polyimine (a-1) prepared in Polyimine Synthesis Example 1 and Polylysine (b-1) prepared in Polyamine Synthesis Example 1 as Polyimine : Polyglycine = 2 0 : 8 0 (weight ratio) dissolved in γ - butyrolactone / N - methyl - 2 - pyrrolidone / butyl cellosolve mixed solvent (weight ratio 7 1 / 1 7 / 1 2 ) , adding 2 parts by weight of ruthenium, osmium, iridium, Ν'-tetraglycidyl-4,4'-diaminodiphenylmethane relative to 100 parts by weight of polyimine and polyaminic acid And adding 10 parts by weight of the specific compound Α -1 to a solution having a solid concentration of 3.6 wt% and a solution of 6.0 wt% with respect to 1 〇 0 parts by weight of the total of the polyimine and the polyaminic acid. . After the respective solutions were thoroughly stirred, they were filtered through a filter having a pore size of 1 μm to prepare a liquid crystal alignment agent of the present invention. A solution having a solid concentration of 3.5% in the above liquid crystal alignment agent was applied to a transparent conductive film made of an ITO film provided on one surface of a glass substrate having a thickness of 1 mm using a spin coater (rotation speed: 25) 00 rpm, coating time: 1 minute), the solvent was removed by heating at 200 ° C for 1 hour to form a coating film having a film thickness of 0.08 μm. The coating film was sanded using a grinding machine equipped with a roll of a woven fabric made of rayon, with a roll speed of 400 rpm, a table moving speed of 3 cm/sec, and a fluffing length of 0 · 4 mm. . After the ultra-pure liquid crystal alignment film-coated substrate of -49-200832019, the outer surface of the liquid liquid crystal alignment film of the bright electrode/transparent electrode substrate is dried in a clean oven at 1 ° C, except that the liquid crystal diameter is The epoxy crystal of the 5 · 5 μ m oxidized crystal ball is relatively heavy and combined with the film surface, and is filled with the liquid crystal injection port to the 歹MLC-6 22 1 ), and then sealed with acrylic light. Liquid crystal display element. In accordance with the voltage holding ratio of the liquid crystal display device, the printability evaluation was carried out by using the method described above for the solid content concentration. Examples 2 to 1 6 In addition to the specific compound, polyimine and the supported compound, the compound of the specific compound Cl, C-2, C-imine and polyglycolic acid was used in the same manner as in the examples. . Example 1 7 Mixing of a pyridyl-2-pyrrolidone/butyl cellosolve prepared in Polyimine Synthesis Example 2 Adding 7 Glyceryl-4,4,-diaminodiphenyl to 100 parts by weight of polyimine The methaneimine was added to 10 parts by weight of the specific compound water and ultrasonically washed for 1 minute and 10 minutes. Then, 'the coating of the pair of through-crystal alignment film-coated substrates is applied', and the resin adhesive agent' is then applied to cure the adhesive. Then, [J-type liquid crystal (Merck's production of 'curing adhesive' will be evaluated by the method described above for the liquid crystal injection port. The 6.0% by weight solution, according to the] polylysine use table The same procedure as described in 1 is carried out. When 3 or C is 4, 20 parts by weight of these tert-polyimine (a-2) is dissolved in N-methyl solvent relative to the polybenzal (weight) In the ratio of 5 0/ 5 0), the weight of N, N, N', N'-tetrahydration is further reduced to 100 parts by weight relative to 100 parts by weight of polyfluorene A - 1, and the solid concentration is -50-200832019. a solution of 5 wt% and a solution of 6.0% by weight. After thoroughly stirring each solution, the solution is filtered with a filter having a pore size of 1 μm to prepare a liquid crystal alignment agent of the present invention. The evaluation method of the device and the evaluation method of the printability of the alignment agent were carried out in the same manner as in Example 1. Example 1 8 to 2 4 In addition to the use of the substance described in Table 1, the compound of the compound of Example 17 was replaced. Except for -1, the same procedure as in Example 17 was carried out. When compound C1, C-2, C-3 or C-4 is used, relative to 100 parts by weight of polyimine, 20 parts by weight of these specific compounds are used. 1 ° Comparative Examples 1, 2 except for polyimine and polyfluorene The amine was used in the same manner as in Example 1 except that the compound stomach described in Table 1 was used without adding a specific compound. Comparative Example 3 In the same manner as in Example 1 except that no specific compound was added, w The process is carried out. The results of the above examples and comparative examples are all listed in Table 1 ° and # ' Table 1, "1, which means that the component in the column is not used. In addition, the ' ® pressure retention rate is blocked. ">99%" means that the measured enthalpy exceeds 99%. -51 - 200832019 Table 1 Specific compound polyimine polyamine acid voltage retention rate image-printing Example 1 A-1 a-1 b-1 > 99% 〇〇 Example 2 A-2 a-1 b-1 > 99% 〇〇 Example 3 A-3 a-1 b-1 > 99% 〇〇 Example 4 B-1 a-1 b -1 >99% 〇〇Example 5 C-1 a-1 b-1 >99% 〇〇Example 6 C-2 a-1 b-1 >99% 〇〇Example 7 C-3 A-1 b-1 >99% 〇〇 Example 8 C-4 a-1 b-1 > 99% 〇〇 Example 9 A-1 a-1 b-2 > 99% 〇〇 Example 10 A-2 a-1 b-2 > 99% 〇〇 Example 11 A-3 a-1 b-2 > 99% 〇〇 Example 12 B — 1 a-1 b-2 > 99% 〇〇 Example 13 C-1 a-1 b -2 >99% 〇〇Example 14 C-2 a-1 b-2 >99% 〇〇Example 15 C 3-1 a-2 b-2 >99% 〇〇Example 16 C-4 A-1 b-2 > 99% 〇〇 Example 17 A-1 a-2 — > 99% 〇〇 Example 18 A-2 a-2 — > 99% 〇〇 Example 19 A-3 A-2 — > 99% 〇〇 Example 20 B — 1 a-2 — > 99% 〇〇 Example 21 C —1 a — 2 — > 99% 〇〇 Example 22 C-2 a— 2 - > 99% 〇〇 Example 23 C - 3 a-2 - > 99% 〇〇 Example 24 C - 4 a - 2 - > 99% 〇〇 Comparative Example 1 - a-1 b-1 >99% X 〇Comparative Example 2 - a-1 b-2 >99% X 〇Comparative Example 3 - a-2 - >99% X 〇-52- 200832019 [Simplified Schematic] Figure 1 Schematic diagram of the unit cell produced by the afterimage experiments of the examples and comparative examples.

Claims (1)

200832019 十、申請專利範圍: 1.一種液晶配向劑,其特徵在於含有下述通式(1)表示的 化合物, R\ 尸 N—Y—N—X—N—Y—N ( 1 ) R2 A B V (式中,A和B各自獨立地爲氫原子或者縮水甘油基, R1〜R4各自獨立地爲氫原子或者縮水甘油基,X爲下 述式(XI)或(X2)表示的2價基團),200832019 X. Patent application scope: 1. A liquid crystal alignment agent characterized by containing a compound represented by the following formula (1), R\ corpse N-Y-N-X-N-Y-N(1) R2 ABV (wherein, A and B are each independently a hydrogen atom or a glycidyl group, and R1 to R4 are each independently a hydrogen atom or a glycidyl group, and X is a divalent group represented by the following formula (XI) or (X2); ), (X1)(X1) (X2) Y爲下述式(Yl)、(Y2)或(Y3)表示的2價基團, -54- 200832019(X2) Y is a divalent group represented by the following formula (Yl), (Y2) or (Y3), -54- 200832019 (式中,R5〜R14各自獨立地爲氫原子、烷基、烷氧基或 含氣院基,Z爲一〇一、一NH—、一 CH2—、一 S〇2—、 —C(CH3)2 —或者—C(CF3)2 —表示的2價基團))。 2 .如申請專利範圍第1項之晶配向劑,其中式(1)中,γ爲 上述式(Y1)或(Y2)表示的2價基團。 3 ·如申請專利範圍第1或2項之液晶配向劑,其中式(1)中, A和B爲氫原子,Rl〜R4各自獨立地爲氫原子或縮水甘 油基,但R 1〜R 4中至少一個爲縮水甘油基。 )表示 4 . 一種液晶配向劑’其特徵在於含有由下述通式(1, -55- 200832019 的化合物與四羧酸二酐反應所得的聚醯胺 R1(wherein R5 to R14 are each independently a hydrogen atom, an alkyl group, an alkoxy group or a gas-containing courtyard group, and Z is a mono-, an NH-, a CH2-, a S〇2-, a C-CH3 ) 2 — or —C(CF3) 2 — represents a divalent group)). 2. The crystal alignment agent according to claim 1, wherein in the formula (1), γ is a divalent group represented by the above formula (Y1) or (Y2). 3. The liquid crystal alignment agent according to claim 1 or 2, wherein in the formula (1), A and B are a hydrogen atom, and R1 to R4 are each independently a hydrogen atom or a glycidyl group, but R 1 to R 4 At least one of them is a glycidyl group. Representation 4. A liquid crystal alignment agent' characterized by containing a polyamine R1 obtained by reacting a compound of the following formula (1, -55-200832019 with a tetracarboxylic dianhydride) 1 R2,/ N—Y—N—X—N—Y—N (r) A B R1,〜R4,爲 配向劑,其 的重複單元 單元的聚醯 (式中,A、B、X和Y與上述通式(1)相同 氧原子)。 5 .如申請專利範圍第1至4項中任一項之液 中進一步含有選自由具有下述式(I 一 1)表 的聚醯胺酸和具有下述式(I - 2)表示的重 亞胺所構成之群組的至少一種,1 R2, / N - Y - N - X - N - Y - N (r) AB R1, ~ R4, is an alignment agent, the poly unit of the repeating unit (in the formula, A, B, X and Y and The above formula (1) is the same oxygen atom). 5. The liquid according to any one of claims 1 to 4, further comprising a polyphosphonic acid selected from the group consisting of the following formula (I-1) and having a weight represented by the following formula (I-2) At least one of the groups consisting of imines, HOOC、 .COOH/吹 ΉΝΟΟ CONH-HOOC, .COOH/Blowing CONH- (1-1) (式中,P1爲4價的有機基團,且Q1爲2價的有機基團), 200832019(1-1) (wherein P1 is a tetravalent organic group, and Q1 is a divalent organic group), 200832019 (式中,P2爲4價的有機基團,且Q2爲2價的有機基團)。 { 6.如申請專利範圍第5項之液晶配向劑,其中含有具有上 述式(I - 1)表示的重複單元的聚醯胺酸和具有上述式(I -2)表示的重複單元的聚醯亞胺,且該等聚醯胺酸和聚醯亞 胺是由包含 2,3 , 5 -三羧基環戊基醋酸二酐的四羧酸二酐 與二胺所合成。 7. —種液晶顯示元件,其特徵在於具有由如申請專利範圍 第1至6項中任一項之液晶配向劑所形成的液晶配向膜 -57-(In the formula, P2 is a tetravalent organic group, and Q2 is a divalent organic group). {6> The liquid crystal alignment agent of claim 5, which comprises a polylysine having a repeating unit represented by the above formula (I-1) and a polyfluorene having a repeating unit represented by the above formula (I-2) An imine, and the polyamic acid and polyimine are synthesized from a tetracarboxylic dianhydride and a diamine containing 2,3,5-tricarboxycyclopentyl acetic acid dianhydride. A liquid crystal display element characterized by having a liquid crystal alignment film formed of a liquid crystal alignment agent according to any one of claims 1 to 6 - 57-
TW096141960A 2006-11-08 2007-11-07 Liguid crystal alignment agent and liquid crystal display element TW200832019A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006303297 2006-11-08

Publications (1)

Publication Number Publication Date
TW200832019A true TW200832019A (en) 2008-08-01

Family

ID=39404827

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096141960A TW200832019A (en) 2006-11-08 2007-11-07 Liguid crystal alignment agent and liquid crystal display element

Country Status (4)

Country Link
JP (1) JP4978433B2 (en)
KR (1) KR20080042014A (en)
CN (1) CN101178519A (en)
TW (1) TW200832019A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5668922B2 (en) * 2010-03-01 2015-02-12 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
KR102096126B1 (en) * 2012-08-10 2020-04-01 닛산 가가쿠 가부시키가이샤 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP6492564B2 (en) * 2014-02-13 2019-04-03 Jsr株式会社 Liquid Crystal Alignment Agent, Liquid Crystal Alignment Film, Liquid Crystal Display Element, Retardation Film, Method of Producing Retardation Film, Polymer, and Compound
JP6888241B2 (en) * 2015-04-08 2021-06-16 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, method for manufacturing liquid crystal alignment film, liquid crystal element and method for manufacturing liquid crystal element
CN108503832A (en) * 2016-01-12 2018-09-07 湖南工业大学 A kind of polyimides and its preparation method and application containing fluorenes or Fluorenone structure
CN105693539B (en) * 2016-01-12 2019-01-25 湖南工业大学 It is a kind of that there is high flatness diamine monomer and its synthetic method and application containing fluorenes or Fluorenone structure
CN105601920B (en) * 2016-01-13 2018-08-17 湖南工业大学 A kind of polyimide nano-composite material and its preparation method and application containing fluorenes or Fluorenone structure
CN108603028B (en) * 2016-02-08 2021-05-07 东丽株式会社 Resin composition, resin layer, temporary adhesive, laminated film, wafer processed body, and application thereof
KR20180070262A (en) 2016-12-16 2018-06-26 엘지디스플레이 주식회사 Substrate, Liquid Crystal Display Device Including The Same And Method Of Fabricating The Same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE659544C (en) * 1935-12-01 1938-05-05 I G Farbenindustrie Akt Ges Process for the preparation of p, p'-diaminodiphenylbenzidines
JP3536925B2 (en) * 1993-05-18 2004-06-14 チッソ株式会社 Liquid crystal alignment film and liquid crystal display device
JP2000044683A (en) * 1998-07-29 2000-02-15 Nissan Chem Ind Ltd Diamine having oligo-aniline unit and polyimide
CN100345907C (en) * 2001-06-12 2007-10-31 日产化学工业株式会社 Liquid crystal orientation agents and liquid crystal display device with use thereof

Also Published As

Publication number Publication date
JP2008139862A (en) 2008-06-19
KR20080042014A (en) 2008-05-14
JP4978433B2 (en) 2012-07-18
CN101178519A (en) 2008-05-14

Similar Documents

Publication Publication Date Title
TW200832019A (en) Liguid crystal alignment agent and liquid crystal display element
TW200804937A (en) Liquid crystal alignment agent and liquid crystal display device
TW200811553A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW200946563A (en) Liquid crystal aligning agent and liquid crystal display element
JP5083539B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5019049B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI358006B (en) Liquid crystal alignment agent and liquid crystal
JP5105071B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP2008090297A (en) Liquid crystal aligning agent and liquid crystal display element
TWI354843B (en) Liquid crystal alignment agent and liquid crystal
TW200819510A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI442144B (en) Liquid crystal alignment agent and liquid crystal display element
JP2008107814A (en) Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display element
TWI428370B (en) Liquid crystal aligning agent and liquid crystal display element
TWI461460B (en) Liquid aligning agent liquid crystal aligning film and liquid crystal display element
JP5077558B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5224034B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TW200837459A (en) Liquid crystal alignment agent and liquid crystal display element
TW200831562A (en) Liquid crystal alignment agent and liquid crystal display element
TWI457421B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP5088563B2 (en) Liquid crystal aligning agent and liquid crystal display element
TW200925181A (en) Liquid crystal alignmenting agent and transverse electric field type liquid crystal display element
TW200821715A (en) Liquid crystal alignment agent and liquid crystal display element
JP5071659B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5099351B2 (en) Liquid crystal aligning agent and liquid crystal display element